WO1997025929A1 - Expandable-collapsible electrode structures for capacitive coupling to tissue - Google Patents
Expandable-collapsible electrode structures for capacitive coupling to tissue Download PDFInfo
- Publication number
- WO1997025929A1 WO1997025929A1 PCT/US1997/001174 US9701174W WO9725929A1 WO 1997025929 A1 WO1997025929 A1 WO 1997025929A1 US 9701174 W US9701174 W US 9701174W WO 9725929 A1 WO9725929 A1 WO 9725929A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wall
- tissue
- shell
- expandable
- electrically conductive
- Prior art date
Links
- 230000008878 coupling Effects 0.000 title claims abstract description 23
- 238000010168 coupling process Methods 0.000 title claims abstract description 23
- 238000005859 coupling reaction Methods 0.000 title claims abstract description 23
- 239000004020 conductor Substances 0.000 claims abstract description 42
- 150000002500 ions Chemical class 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims description 44
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 22
- 239000012530 fluid Substances 0.000 claims description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 15
- 229910052697 platinum Inorganic materials 0.000 claims description 11
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 6
- 229910052737 gold Inorganic materials 0.000 claims description 6
- 239000010931 gold Substances 0.000 claims description 6
- 229910052741 iridium Inorganic materials 0.000 claims description 6
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 claims description 5
- 239000004033 plastic Substances 0.000 claims description 5
- 229920003023 plastic Polymers 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 239000007769 metal material Substances 0.000 claims description 4
- 239000010935 stainless steel Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000000819 hypertonic solution Substances 0.000 claims 2
- 229940021223 hypertonic solution Drugs 0.000 claims 2
- 230000000712 assembly Effects 0.000 abstract description 5
- 238000000429 assembly Methods 0.000 abstract description 5
- 239000011257 shell material Substances 0.000 description 198
- 210000001519 tissue Anatomy 0.000 description 148
- 230000003902 lesion Effects 0.000 description 73
- 238000002679 ablation Methods 0.000 description 68
- 238000000034 method Methods 0.000 description 50
- 238000001816 cooling Methods 0.000 description 33
- 230000000694 effects Effects 0.000 description 30
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 230000006870 function Effects 0.000 description 22
- 239000000853 adhesive Substances 0.000 description 16
- 230000001070 adhesive effect Effects 0.000 description 16
- 239000011888 foil Substances 0.000 description 16
- 230000005540 biological transmission Effects 0.000 description 15
- 244000309464 bull Species 0.000 description 14
- 238000000151 deposition Methods 0.000 description 14
- 210000003739 neck Anatomy 0.000 description 14
- 230000008021 deposition Effects 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 230000007246 mechanism Effects 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000006260 foam Substances 0.000 description 8
- 238000007674 radiofrequency ablation Methods 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 239000002826 coolant Substances 0.000 description 7
- 238000000465 moulding Methods 0.000 description 7
- 230000008859 change Effects 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 230000006835 compression Effects 0.000 description 5
- 238000007906 compression Methods 0.000 description 5
- 239000012777 electrically insulating material Substances 0.000 description 5
- 210000002569 neuron Anatomy 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 206010047302 ventricular tachycardia Diseases 0.000 description 5
- 239000004642 Polyimide Substances 0.000 description 4
- 238000013528 artificial neural network Methods 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000013153 catheter ablation Methods 0.000 description 4
- 238000013507 mapping Methods 0.000 description 4
- 230000000873 masking effect Effects 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 230000002107 myocardial effect Effects 0.000 description 4
- 210000004205 output neuron Anatomy 0.000 description 4
- 229920001721 polyimide Polymers 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 239000003990 capacitor Substances 0.000 description 3
- 210000005242 cardiac chamber Anatomy 0.000 description 3
- 230000001808 coupling effect Effects 0.000 description 3
- 238000005336 cracking Methods 0.000 description 3
- 238000005137 deposition process Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000010292 electrical insulation Methods 0.000 description 3
- 239000000076 hypertonic saline solution Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000007747 plating Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 206010003662 Atrial flutter Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229910052775 Thulium Inorganic materials 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000746 body region Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000005094 computer simulation Methods 0.000 description 2
- 229920001940 conductive polymer Polymers 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000009713 electroplating Methods 0.000 description 2
- 238000004880 explosion Methods 0.000 description 2
- 210000005003 heart tissue Anatomy 0.000 description 2
- 210000002364 input neuron Anatomy 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 238000007737 ion beam deposition Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000001013 sinoatrial node Anatomy 0.000 description 2
- 238000005476 soldering Methods 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000007740 vapor deposition Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000013022 venting Methods 0.000 description 2
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 229910001006 Constantan Inorganic materials 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical group [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 210000001992 atrioventricular node Anatomy 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 239000002783 friction material Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 230000001453 nonthrombogenic effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- -1 polyethelene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 238000010248 power generation Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/06—Electrodes for high-frequency therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/145—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/145—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00039—Electric or electromagnetic phenomena other than conductivity, e.g. capacity, inductivity, Hall effect
- A61B2017/00044—Sensing electrocardiography, i.e. ECG
- A61B2017/00048—Spectral analysis
- A61B2017/00053—Mapping
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22061—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation for spreading elements apart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00065—Material properties porous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00071—Electrical conductivity
- A61B2018/00083—Electrical conductivity low, i.e. electrically insulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00089—Thermal conductivity
- A61B2018/00095—Thermal conductivity high, i.e. heat conducting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00107—Coatings on the energy applicator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00107—Coatings on the energy applicator
- A61B2018/00113—Coatings on the energy applicator with foam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00107—Coatings on the energy applicator
- A61B2018/00148—Coatings on the energy applicator with metal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/00267—Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00839—Bioelectrical parameters, e.g. ECG, EEG
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/1253—Generators therefor characterised by the output polarity monopolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1472—Probes or electrodes therefor for use with liquid electrolyte, e.g. virtual electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
- A61B2218/002—Irrigation
Definitions
- the invention generally relates to electrode structures deployed in interior regions of the body. In a more specific sense, the invention relates to electrode structures deployable into the heart for diagnosis and treatment of cardiac conditions.
- the treatment of cardiac arrhythmias requires electrodes capable of creating tissue lesions having a diversity of different geometries and characteristics, depending upon the particular physiology of the arrhythmia sought to be treated.
- a conventional 8F diameter/4mm long cardiac ablation electrode can transmit radio frequency energy to create lesions in myocardial tissue with a depth of about 0.5 cm and a width of about 10 mm, with a lesion volume of up to 0.2 cm 3 .
- VT ventricular tachycardia
- Multi-purpose cardiac ablation electrodes that can selectively create lesions of different geometries and characteristics.
- Multi-purpose electrodes would possess the flexibility and maneuverability permitting safe and easy introduction into the heart. Once deployed inside the heart, these electrodes would possess the capability to emit energy sufficient to create, in a controlled fashion, either large and deep lesions, or small and shallow lesions, or large and shallow lesions, depending upon the therapy required.
- the invention provides electrode assemblies and associated systems employing a nonporous wall having an exterior for contacting tissue.
- the exterior peripherally surrounds an interior area.
- the wall is essentially free of electrically conductive material.
- the wall is adapted to assume an expanded geometry having a first maximum diameter and a collapsed geometry having a second maximum diameter less than the first maximum diameter.
- the assemblies and systems include a lumen that conveys a medium containing ions into the interior area.
- An element free of physical contact with the wall couples the medium within the interior area to a source of electrical energy to enable ionic transport of electrical energy from the source through the medium to the wall for capacitive coupling to tissue contacting the exterior of the wall.
- the capacitive coupling of the wall is expressed in the following relationship:
- K is a constant that depends upon geometry of the wall
- S E is surface area of the element, and p s is resistivity of the medium containing ions, and where:
- ⁇ is the dielectric constant of wall
- the invention also provides systems and methods for heating or ablating body tissue.
- the systems and methods provide a catheter tube having a distal end that carries an electrode of the type described above.
- the systems and methods electrically couple a source of radio frequency energy to the electrically conductive element within the electrode body and to a return electrode in contact with body tissue.
- the systems and methods guide the catheter tube into a body with the wall in the collapsed geometry and then cause the wall to assume the expanded geometry at least in part by conveying a medium containing ions into the interior area of the body.
- the systems and methods then ohmically heat or ablate body tissue by transmitting radio frequency energy to the electrically conductive element for ionic transport through the medium to the wall for capacitive coupling to tissue located between the return electrode and the electrode.
- FIG. 1 is a plan view of a system for ablating heart tissue, which includes an expandable electrode structure that embodies the features of the invention
- Fig. 2 is a side elevation view of an expandable electrode structure usable in association with the system shown in Fig. 1, in which an inflation medium is used to expand the structure;
- Fig. 3A is a side elevation view of an alternative expandable electrode structure usable in association with the system shown in Fig. 1, in which an inflation medium is used to expand separate multiple chambers within the structure;
- Fig. 3B is a side elevation view of an alternative expandable electrode structure usable in association with the system shown in Fig. 1, in which an inflation medium is used to expand integrally formed multiple chambers within the structure;
- Fig. 3C is a top section view of the electrode structure shown in Fig. 3B, taken generally along line 3C-3C in Fig. 3B;
- Fig. 3D is a side elevation view of an alternative expandable electrode structure usable in association with the system shown in Fig. 1, in which an inflation medium is used to expand a single chamber within the structure;
- Fig. 3E is a top view of an alternative expandable-collapsible electrode structure with a body having interior coextruded webs that compartmentalize the body into multiple interior chambers;
- Fig. 4 is a side elevation view of an alternative expandable electrode structure usable in association with the system shown in Fig. 1, in which an open spline structure is used to expand the structure;
- Fig. 5 is the expandable electrode shown in
- FIG. 4 in which a slidable sheath is used to collapse the structure
- Fig. 6 is a side elevation view of an alternative expandable electrode structure usable in association with the system shown in Fig. 1, in which an interwoven mesh structure is used to expand the structure
- Fig. 7 is the expandable electrode shown in
- Fig. 6 in which a slidable sheath is used to collapse the structure
- Fig. 8 is a side elevation view of an alternative expandable interwoven mesh electrode structure usable in association with the system shown in Fig. 1, in which an interior bladder is used to expand the structure;
- Fig. 9 is a side elevation view of an alternative expandable foam electrode structure usable in association with the system shown in Fig. i;
- Fig. 10 is a side elevation view of an alternative expandable electrode structure usable in association with the system shown in Fig. 1, in which an electrically actuated spline structure is used to expand the structure;
- Fig. 11A is a side elevation view of an alternative expandable electrode structure usable in association with the system shown in Fig. l, in which the electrode structure is pleated or creased to promote folding upon collapse;
- Fig. 11B is the electrode shown in Fig. 11A in the process of folding while collapsing
- Fig. lie is the electrode shown in Fig. 11A as folded upon collapse
- Fig. 12 is a side elevation view of an expandable electrode structure usable in association with the system shown in Fig. 1, in which a steering mechanism proximal to the structure steers the structure at the end of a catheter tube;
- Fig. 13 is a side elevation view of an expandable electrode structure usable in association with the system shown in Fig. 1, in which a steering mechanism within the structure steers the structure at the end of a catheter tube;
- Fig. 14 is a side elevation view of an expandable electrode structure usable in association with the system shown in Fig. l, in which an axially and radially movable stilette in the structure is used to alter the shape of the structure;
- Figs. 15A to 15E are plan views of an assembly process for manufacturing an expandable electrode structure using an inflation medium to expand the structure
- Figs. 16A to 16D are plan views of an assembly process for manufacturing an expandable electrode structure using an interior spline structure to expand the structure
- Fig. 17 is a side elevation view of an expandable electrode structure usable in association with the system shown in Fig. 1, in which an electrically conductive shell is deposited on the distal end of the structure;
- Fig. 18 is a side elevation view of an expandable electrode structure usable in association with the system shown in Fig. 1, in which an electrically conductive foil shell is positioned for attachment on the distal end of the structure;
- Fig. 19 is an enlarged section view of the wall of an expandable electrode structure usable in association with the system shown in Fig. 1, in which an electrically conductive material is coextruded within the wall;
- Fig. 20 is a top view of an expandable electrode structure having an exterior shell of electrically conductive material formed in a segmented bull's-eye pattern;
- Figs. 21 and 22 are, respectively, side and top views of an expandable electrode structure having an exterior shell of electrically conductive material formed in a segmented pattern of energy transmission zones circumferentially spaced about a preformed, foldable body, and including multiple temperature sensing elements;
- Figs. 23, 24A, and 24B are enlarged side views showing the deposition of electrically conductive material to establish fold lines on the exterior of an expandable electrode structure;
- Fig. 25 is a top view of an expandable electrode structure showing the preferred regions for attaching signal wires to an electrically conductive shell deposited on the distal end of the structure;
- Fig. 26 is a side view of an expandable electrode structure showing the preferred regions for attaching signal wires to an electrically conductive shell deposited in a circumferentially segmented pattern on the structure;
- Fig. 27 is a top view of an expandable electrode structure showing the preferred regions for attaching signal wires to an electrically conductive shell deposited in a bull's-eye pattern on the structure;
- Figs. 28A and 28B are, respectively side section and top views showing the attachment of signal walls to an electrically conductive shell deposited on the distal end of the structure, the signal wires being led through the distal end of the structure;
- Fig. 29A is an enlarged side view of the distal end of an expandable electrode structure usable in association with the system shown in Fig. 1, showing the attachment of an ablation energy signal wire to the electrically conductive shell using a mechanical fixture at the distal end of the structure;
- Fig. 29B is an enlarged exploded side view, portions of which are in section, of the mechanical fixture shown in Fig. 29A;
- Figs. 30 and 31 are side section views showing the attachment of a signal wire to an electrically conductive shell, the signal wire being snaked through the wall of the structure either one (Fig. 30) or multiple times (Fig. 31) ;
- Fig. 32 is an enlarged section view of the wall of an expandable electrode structure usable in association with the system shown in Fig. 1, showing the laminated structure of the wall and the attachment of an ablation energy signal wire to the electrically conductive shell using laser windowing techniques;
- Fig. 33 is a side view, with portions broken away and in section, of an expandable electrode structure usable in association with the system shown in Fig. 1, showing the attachment of a temperature sensing element to a fixture at the distal end of the structure;
- Fig. 34 is an enlarged side section view of the wall of an expandable electrode structure usable in association with the system shown in Fig. 1, showing ways of attaching temperature sensing elements inside and outside the wall;
- Fig. 35 is an enlarged side section view of the wall of an expandable electrode structure usable in association with the system shown in Fig. 1, showing a laminated structure and the creation of temperature sensing thermocouples by laser windowing and deposition;
- Fig. 36 is a top view of an expandable electrode structure showing the preferred regions for attaching temperature sensing elements with respect to an electrically conductive shell deposited on the distal end of the structure;
- Fig. 37 is a side view of an expandable electrode structure showing the preferred regions for attaching temperature sensing elements with respect to an electrically conductive shell deposited in a circumferentially segmented pattern on the structure;
- Fig. 38 is a top view of an expandable electrode structure showing the preferred regions for attaching temperature sensing elements with respect to an electrically conductive shell deposited in a bull's-eye pattern on the structure;
- Fig. 39 is a side view of an expandable electrode structure showing a pattern of holes for cooling the edge regions of an electrically conductive shell deposited in a circumferentially segmented pattern on the structure, the pattern of holes also defining a fold line between the segments of the pattern;
- Figs. 40A and 40B are enlarged views of a hole formed in the structure shown in Fig. 39, showing that the hole defines a fold line;
- Fig. 41A is a side sectional view of an expandable electrode structure usable in association with the system shown in Fig. 1, which is capacitively coupled to tissue;
- Fig. 41B is a diagrammatic view showing the electrical path that ablation energy follows when the electrode shown in Fig. 40A is capacitively coupled to tissue;
- Fig. 42A is an side sectional view of an alternative expandable electrode structure usable in association with the system shown in Fig. l, which is capacitively coupled to tissue;
- Fig. 42B is a diagrammatic view showing the electrical path that ablation energy follows when the electrode shown in Fig. 41A is capacitively coupled to tissue;
- Fig. 43 is a diagrammatic view of neural network usable for predicting maximum temperature conditions when the expandable-collapsible electrode structure carries multiple ablation energy transmitting segments;
- Fig. 44 is a side elevation view of an expandable electrode structure that embodies the features of the invention, used in association with pacing and sensing electrodes.
- the invention may be embodied in several forms without departing from its spirit or essential characteristics.
- the scope of the invention is defined in the appended claims, rather than in the specific description preceding them. All embodi- ments that fall within the meaning and range of equivalency of the claims are therefore intended to be embraced by the claims. Description of the Preferred Embodiments
- FIG. 1 shows a tissue ablation system 10 that embodies the features of the invention.
- the system 10 includes a flexible catheter tube 12 with a proximal end 14 and a distal end 16.
- the proximal end 14 carries a handle 18.
- the distal end 16 carries an electrode structure 20, which embodies features of the invention.
- the purpose of the electrode structure 20 is to transmit ablation energy.
- the electrode structure 20 includes an expandable-collapsible wall forming a body 22.
- the geometry of the body 22 can be altered between an enlarged, or expanded, geometry having a first maximum diameter (depicted in various forms, for example, in Figs.
- the expandable- collapsible body 22 can assume a collapsed, low profile (ideally, less than 8 French diameter, i.e., less than about 0.267 cm) when introduced into the vasculature. Once located in the desired position, the expandable-collapsible body 22 can be urged into a significantly expanded geometry of, for example, approximately 7 to 20 mm.
- the electrically conductive material comprises an electrically conductive shell 24 overlying all or a portion of the expandable-collapsible body 22.
- the shell 24 serves as the transmitter of energy that ablates body tissue. While the type of ablation energy used can vary, in the illustrated and preferred embodiment, the shell 24 serves to transmit radio frequency (RF) electromagnetic energy.
- RF radio frequency
- the shell 24 is flexible enough to adopt to the range of geometries, from collapsed to expanded, that the expandable-collapsible body 22 assumes. Still, the shell 24 preferably resists stretching within this range, to thereby minimize "thinning.” Thinning of the shell 24 creates localized changes to the shell 24, with attendant increases in resistance and "hot spots.” For this reason, the elasticity of the expandable-collapsible body 22 and shell 24 should be selected to fall within acceptable bounds so that the ability to fold is retained while preserving stability during inflation. Further details of the energy transmitting shell 24 will be provided later. As will be shown in greater detail later (see Figs. 25 to 32) , the shell 24 is coupled to one or more signal wires 26. The signal wires 26 extend from the shell 24, through the catheter tube 12, to external connectors 28 on the handle 18 (see Fig. 1) . The connectors 28 electrically couple the shell 24 to a radio frequency generator 30.
- a controller 32 is associated with the generator 30, either as an integrated unit or as a separate interface box.
- the controller 32 governs the delivery of radio frequency ablation energy to the shell 24 according to preestablished criteria. Further details of this aspect of the system 10 will be described later.
- the system 10 as just described is suited for ablating myocardial tissue within the heart.
- a physician moves the catheter tube 12 through a main vein or artery into a heart chamber, while the expandable-collapsible body 22 of the electrode structure 20 is in its low profile geometry. Once inside the desired heart chamber, the expandable-collapsible body 22 is enlarged into its expanded geometry, and the shell 24 is placed into contact with the targeted region of endocardial tissue.
- Radio frequency energy is conveyed from the generator 30 to the shell 24, as governed by the controller 32.
- the shell 24 transmits radio frequency energy into tissue to a return electrode, which is typically an external patch electrode (forming a unipolar arrangement) .
- the transmitted energy can pass through tissue to an adjacent electrode in the heart chamber (forming a bipolar arrangement) , or between segments in the shell 24, as will be described later (also forming a bipolar arrangement) .
- the radio frequency energy heats the tissue forming a lesion.
- the expanded geometry of the expandable- collapsible body 22 enhances the energy transmission characteristics of the structure 20.
- the structure 20, when expanded, is able to form tissue lesions that are significantly larger in terms of size and volume than the body's initial collapsed profile during introduction would otherwise provide.
- the expandable-collapsible electrode structure 20 as just described is also suited for mapping myocardial tissue within the heart.
- the shell 24 senses electrical activity in the heart. The sensed electrical activity is conveyed to an external monitor, which processes the potentials for analysis by the physician.
- the use of an expandable- collapsible electrode structure for this purpose is generally disclosed in Edwards et al. U.S. Patent 5,293,869.
- the expandable-collapsible electrode structure 20 can be used alternatively, or in combination with sensing electrical activities, to convey pacing signals. In this way, the structure 20 can carry out pace mapping or entrainment mapping.
- the expanded electrode structure 20 can also be used to convey pacing signals to confirming contact with tissue before ablating.
- the ability to carry out pacing to sense tissue contact is unexpected, given that the expanded structure 20 presents a surface area significantly greater than that presented by a conventional 4mm/8F electrode.
- the catheter tube 20 can also carry one or more conventional ring electrodes 21 for bipolar sensing.
- a conventional pacing or unipolar sensing electrode 23 may also be provided, appended at the distal end of the structure 20.
- the Expandable-Collapsible Body The expandable-collapsible body 22 is made from a material selected to exhibit the following characteristics:
- the material must be capable, in use, of transition between an expanded geometry having a first maximum diameter and a collapsed geometry having a second maximum diameter less than the first diameter.
- the material can be formed into an expandable-collapsible bladder or balloon body having an open interior.
- the body is flexible enough to assume the expanded geometry as a result of a normally open solid support structure within the interior, or the opening of a normally closed support structure within the interior, or the introduction of fluid pressure into the interior, or a combination of such interior forces.
- the body is caused to assume the collapsed geometry by an exterior compression force against the normally open interior support structure, or the closing of the interior support structure, or the removal of the interior fluid pressure, or a combination of such offsetting forces.
- the material can be a preformed body with a memory urging it toward a normally expanded geometry.
- the preformed body is caused to assume the collapsed geometry by the application of an external compression force.
- the preformed body can have an open interior, or can comprise, for example, a collapsible composite foam structure.
- the material must be biocompatible and able to withstand high temperature conditions, which arise during manufacture and use.
- the material must possess sufficient strength to withstand, without rupture or tearing, external mechanical or fluid forces, which are applied to support and maintain its preformed geometry during use.
- the material must lend itself to attachment to the catheter tube 12 through the use of straightforward and inexpensive adhesive, thermal, or mechanical attachment methods.
- the material must be compatible with the electrically conductive shell 24 to achieve secure adherence between the two.
- Thermoplastic or elastomeric materials that can be made to meet these criteria include polyimide (kapton) , polyester, silicone rubber, nylon, mylar, polyethelene, polyvinyl chloride, and composite structures using these and other materials.
- the incidence of tissue sticking to the exterior of the body 22 during use can be mediated by the inclusion of low friction materials like PTFE.
- the propensity of the exterior of the body 22 to cause blood clotting and/or embolization can be reduced by incorporating non-thrombogenic material onto or into the exterior of the body 22.
- Polyimide is particularly preferred for the expandable-collapsible body.
- Polyimide is flexible, but it is not elastic. It can withstand very high temperatures without deformation. Because polyimide is not elastic, it does not impose stretching forces to the shell, which could lead to electrical conductivity decreases, as above described.
- the expandable-collapsible body 22 can be formed about the exterior of a glass mold. In this arrangement, the external dimensions of the mold match the desired expanded internal geometry of the expandable-collapsible body 22.
- the mold is dipped in a desired sequence into a solution of the body material until the desired wall thickness is achieved. The mold is then etched away, leaving the formed expandable-collapsible body 22.
- the preferred geometry is essentially spherical and symmetric, with a distal spherical contour, as Figs. 2 to 11 show in various forms.
- nonsymmetric geometries can be used.
- the expandable-collapsible body 22 may be formed with a flattened distal contour, which gradually curves or necks inwardly for attachment with the catheter tube 12.
- the expandable-collapsible body 22 may also be blow molded from extruded tube.
- the body 22 is sealed at one end using a mechanical clamp, adhesive, or thermal fusion.
- the opposite open end of the body 22 is left open.
- the sealed expandable-collapsible body 22 is placed inside the mold.
- An inflation medium, such as high pressure gas or liquid, is introduced through the open tube end.
- the mold is exposed to heat as the tube body 22 is inflated to assume the mold geometry.
- the formed expandable-collapsible body 22 is then pulled from the mold.
- fluid pressure is used to inflate and maintain the expandable-collapsible body 22 in the expanded geometry.
- the catheter tube 12 carries an interior lumen 34 along its length.
- the distal end of the lumen 34 opens into the hollow interior of the expandable-collapsible body 22, which has been formed in the manner just described.
- the proximal end of the lumen 34 communicates with a port 36 (see Fig. 1) on the handle 18.
- An inflation fluid medium (arrows 38 in Fig. 2) is conveyed under positive pressure through the port 36 and into the lumen 34.
- the fluid medium 38 fills the interior of the expandable-collapsible body 22.
- the fluid medium 38 exerts interior pressure to urge the expandable-collapsible body 22 from its collapsed geometry to the enlarged geometry desired for ablation.
- the inflating fluid medium 38 can vary. Preferably, it comprises a liquid such as water, saline solution, or other biocompatible fluid. Alternatively, the inflating fluid medium 38 can comprise a gaseous medium such as carbon dioxide or air.
- the inflation preferably occurs under relatively low pressures of up to 30 psi.
- the pressure used depends upon the desired amount of inflation, the strength and material used for the body 22, and the degree of flexibility required, i.e., high pressure leads to a harder, less flexible body 22.
- More than one fluid conveying lumen 34 may be used.
- the multiple lumens 34 can, for example, speed up the introduction or removal of the inflating medium 38 from the body 22.
- Multiple lumens can also serve to continuously or intermittently recycle the inflating medium 38 within the body 22 for controlling the temperature of the body, as will be described in greater detail later.
- Multiple lumens can also be used, with at least one of the lumens dedicated to venting air from the structure 20.
- a group of sealed bladders compartmentalize the interior of the formed body into chambers 40.
- One or more lumens 42 passing through the catheter tube 12 convey the inflating gas or liquid medium 38 into each chamber 40, as described above.
- the inflated chambers 40 collectively hold the expandable- collapsible body 22 in its expanded condition. Removal of the inflation medium 38 deflates the chambers 40, collapsing the expandable-collapsible body 22.
- the bladders defining the chambers 40 may be separately formed by molding in generally the same fashion as the main expandable-collapsible body 22.
- the bladder material need not have the same resistance to high temperature deformation as the expandable-collapsible body 22. If desired, the bladders may also be deposition coated with a thermal insulating material to thermally insulate them from the main expandable-collapsible body 22.
- the interior chambers 40 can take the form of tubular, circumferentially spaced ribs 41 attached to the interior of the body 22.
- the ribs 41 preferable constitute integrally molded parts of the body 22.
- a single lumen may service all chambers ribs 41.
- multiple lumens individually communicating with each rib 41 provide the ability to more particularly control the geometry of the expanded body 22, by selectively inflating some but not all the ribs 41 or chambers 40.
- the body 22 may be extruded with interior webs 43.
- the interior webs 43 compartmentalize the body 22 into the interior chambers 40, as already described.
- multiple lumens preferably individually communicate with each formed chamber 40 for conveying inflation medium and for venting air.
- a separate, single interior chamber 124 can be used instead of the compartmentalized chambers 40 or ribs 41 shown in Figs. 3A, 3B, and 3C to receive the inflation medium for the exterior body 22.
- this arrangement creates an intermediate region 126 between the interior of the body 22 and the exterior of the chamber 124, through which signal wires 26 can be passed for coupling to the shell 24.
- interior support structures 44 sustain the expandable-collapsible body 22 in the expanded geometry.
- the presence of the interior support structure 44 eliminates the need to introduce air or liquid as an inflation medium 38. Possible difficulties of fluid handling and leakage are thereby avoided.
- the expandable-collapsible body 22 is held in its expanded geometry by an open interior structure 44 formed by an assemblage of flexible spline elements 46.
- the spline elements 46 are made from a resilient, inert wire, like nickel titanium (commercially available as Nitinol material) , or from a resilient injection molded inert plastic or stainless steel.
- the spline elements 46 are preformed in a desired contour and assembled to form a three dimensional support skeleton, which fills the interior space of the expandable-collapsible body 22.
- the supported expandable- collapsible body 22 is brought to a collapsed geometry by outside compression applied by an outer sheath 48 (see Fig. 5) , which slides along the catheter tube 12.
- an outer sheath 48 see Fig. 5 shows, forward movement of the sheath 48 advances it over the expanded expandable-collapsible body 22.
- the sliding sheath 48 encompasses the expandable-collapsible body 22, compressing the interior spline elements 46 together.
- the expandable-collapsible body 22 collapses into its low profile geometry within the sheath 48.
- a sliding sheath 48 (as previously described) can also be advanced along the catheter tube 12 to compress the mesh structure 50 to collapse mesh structure 50 and, with it, the expandable-collapsible body 22. Likewise, retraction of the sheath 48 removes the compression force (as Fig. 6 shows) , and the freed mesh structure 50 springs open to return the expandable- collapsible body 22 back to its expanded geometry.
- the mesh structure 50 itself could serve as the support for the electrically conductive shell 24, without need for the intermediate expandable- collapsible body 22. Indeed, all or a portion of the mesh filaments could be made electrically conductive to themselves serve as transmitters of ablation energy.
- the mesh structure 50 can be made to normally assume the collapsed geometry.
- one or more interior bladders 126 can accommodate the introduction of an inflation medium to cause the mesh structure 50 to assume the expanded geometry.
- the interior bladder 126 could be eliminated.
- a biocompatible liquid such as sterile saline
- Fig. 9 shows yet another alternative expandable- collapsible structure.
- a foam body 128 molded to normally assume the shape of the expanded geometry forms the interior support structure for the body 22.
- the presence of the foam body 128 eliminates the need to introduce air or liquid as an inflation medium.
- a sliding sheath (not shown but as previously described) can be advanced along the catheter tube 12 to compress the foam body 128 and overlying body 22 into the collapsed geometry. Likewise, retraction of the sheath removes the compression force.
- the foam body 128, free of the sheath springs open to return the expandable-collapsible body 22 back to the expanded geometry. It should be appreciated that the foam body 128 can provide interior, normally expanded support to the mesh structure 50 in the same way.
- the geometry of the expandable-collapsible body 22 can be controlled electrically.
- This arrangement includes an assemblage of spline elements 132 within the body 22.
- the spline elements 132 are made of a material that undergoes shape or phase change in response to heating. Nickel titanium wire is a material having this characteristic.
- the spline elements 132 could comprise an assembly of two metals having different coefficients of expansion.
- the body 22 overlies the spline elements 132.
- the spline elements 132 are coupled to an electrical current source 134. Current flow from the source 134 through the spline elements 132 resistively heats the elements 132. As a result, the spline elements 132 change shape.
- the spline elements 132 normally present the collapsed geometry.
- Current flow through the spline elements 132 causes expansion of the elements 132, thereby creating the expanded geometry (as shown by arrows and phantom lines in Fig. 10) .
- the spline elements 132 could alternatively normally present the expanded geometry and be made to contract, thereby assuming the collapsed geometry, in response to current flow.
- the expandable-collapsible body 22 can be molded with preformed regions 52 (see Figs. 11A/B/C) of reduced thickness, forming creases.
- the mold has a preformed surface geometry such that the expandable-collapsible material would be formed slightly thinner, indented, or ribbed along the desired regions 52.
- the use of interior coextruded webs 43 also serves to form the crease regions 52 along the area where the webs 43 contact the interior wall of the body 22.
- the expandable-collapsible body 22 collapses about these regions 52, causing the body 22 to circumferentially fold upon itself in a consistent, uniform fashion.
- the resulting collapsed geometry can thus be made more uniform and compact.
- an inflation medium 38 applies positive pressure to expand the expandable- collapsible body 22
- a negative fluid pressure can be applied inside the expandable-collapsible body 22 to draw the fold regions 52 further inward.
- the fold regions 52 are preferably aligned in the spaces between the spline elements 46 to take best advantage of the prearranged folding action.
- a distal steering mechanism 54 enhances the manipulation of the electrode structure 20, both during and after deployment.
- the steering mechanism 54 can vary.
- the steering mechanism 54 includes a rotating cam wheel 56 coupled to an external steering lever 58 carried by the handle 18.
- the cam wheel 56 holds the proximal ends of right and left steering wires 60.
- the wires 60 pass with the ablation energy signal wires 26 through the catheter tube 12 and connect to the left and right sides of a resilient bendable wire or leaf spring 62 adjacent the distal tube end 16 (see Fig. 12) . Further details of this and other types of steering mechanisms are shown in Lundquist and Thompson U.S.
- FIG. 12 the leaf spring 62 is carried within in the distal end 16 of the catheter tube 12, to which the electrode structure 20 is attached.
- Figs, l and 12 show, forward movement of the steer ⁇ ing lever 58 pulls on one steering wire 60 to flex or curve the leaf spring 62, and, with it, the distal catheter end 16 and the electrode structure 20, in one direction.
- Rearward movement of the steering lever 58 pulls on the other steering wire 60 to flex or curve the leaf spring 62, and, with it, the distal catheter end 16 and the electrode structure 20, in the opposite direction.
- the leaf spring 62 is part of a distal fixture 66 carried within the electrode structure 20 itself.
- the leaf spring 62 extends beyond the distal catheter end 16 within a tube 64 inside the expandable-collapsible body 22.
- the distal end of the leaf spring 62 is secured to a distal fixture 66.
- the distal fixture 66 is itself attached to the distal end of the body 22. Further details of attaching the fixture 66 to the distal end of the body 22 will be described in greater detail later.
- Fig. 13 shows, forward movement of the steer ⁇ ing lever 58 bends the leaf spring 62 in one direction within the expandable-collapsible body 22, deflecting the distal fixture 66 with it. This deforms the expandable-collapsible body 22 in the direction that the leaf spring 62 bends. Rearward movement of the steering lever 58 bends the leaf spring 62 in the opposite direction, having the opposite deformation effect upon the expandable- collapsible body 22.
- the steering mechanism 54 is usable whether the expandable-collapsible body is in its collapsed geometry or in its expanded geometry.
- a stilette 76 is attached to the distal fixture 66.
- the stilette extends inside the body 22, through the catheter tube 12, to a suitable push-pull controller 70 on the handle 18 (see Fig. 1) .
- the stilette 76 is movable along the axis of the catheter tube 12. Moving the stilette 76 forward pushes axially upon the distal fixture 66. Moving the stilette 76 rearward pulls axially upon the distal fixture 66.
- the geometry of the body 22 elongates or expands accordingly.
- the stilette 76 can be used in association with an expandable-collapsible body 22 that is expanded by an inflation medium 38. In this arrangement, when the expandable-collapsible body 22 is collapsed, forward movement of the stilette 76, extends the distal fixture 66 to further urge the expandable-collapsible body 22 into a smaller diameter profile for introduction. When used in association with an expandable- collapsible body 22 that is internally supported by the spline structure 46 or the mesh structure 50, the stilette 76 can be used instead of the slidable outer sheath 48 to expand and collapse the expandable-collapsible body 22.
- Pushing forward upon the stilette 76 extends the spline structure 46 or mesh structure 50 to collapse the expandable- collapsible body 22. Pulling rearward upon the stilette 76, or merely releasing the pushing force, has the opposite effect, allowing the spline structure 46 or mesh structure 50 to assume its expanded geometry.
- the distal end of the stilette 76 near the fixture 66 comprises the bendable leaf spring 62, thereby providing a radial steering function in tandem with the axial push-pull action of the stilette 76.
- a collar 136 is retained by a heat-shrink fit within tubing 64.
- the collar 136 has a central aperture 138 through which a leaf spring 62 at the end of the stilette 76 passes for movement along the axis of the catheter tube 12.
- Steering wires 60 are attached to the collar 136. Pulling on the steering wires 60 radially deflects the collar 136, thereby bending the leaf spring 62 at the end of the stilette 76 in the direction of the pulled steering wire 60.
- a sleeve 78 couples the near end of the expandable-collapsible body 22 to the distal end 16 of the catheter tube.
- the sleeve 78 withstands the forces exerted to expand the expandable-collapsible body 22, resisting separation of the body 22 from the catheter tube 12.
- the sleeve 78 also forms a fluid seal that resists leakage of the medium at inflation pressures.
- the sleeve 78 can be secured about the catheter tube in various ways, including adhesive bonding, thermal bonding, mechanical bonding, screws, winding, or a combination of any of these.
- Figs. 15A to 15E show the details of a preferred assembly process for an expandable-collapsible body 22 whose geometry is altered by use of fluid pressure, such as previously shown in Figs. 2 and 3.
- the body 22 is extruded as a tube 140 having an extruded interior diameter, designated ID, (see Fig. 15A) .
- ID is selected to be less than the exterior diameter of the distal stem 142 of the catheter tube 12 to which the body 22 will ultimately be attached.
- the stem 142 comprises an elongated, stepped-down tubular appendage, which extends beyond the distal end 16 of the catheter tube 12.
- the distal end of the stem 142 is sealed.
- the exterior diameter of the stem 142 is designated in Fig. 15D as ED S .
- the stem 142 includes a central lumen 152 for carrying inflation medium. Spaced apart holes 154 on the stem 142 communicate with the lumen to convey the inflation medium into the body 22, when attached to the stem 142.
- the material of the extruded tube 140 is preferably cross linked by exposure to gamma radiation 168 or an equivalent conventional treatment. The cross linking enhances the capability of the material of the tube 140 to recover its shape after mechanical deformation.
- the extruded tube 140 is mechanically deformed by heat molding into the body 22 having the desired collapsed geometry, in a manner previously described.
- the body geometry includes proximal and distal neck regions 144 and 146 and an intermediate main body region 148.
- the neck regions 144 and 146 have an enlarged interior diameter (designated ID 2 in Fig. 15B) that is slightly greater than catheter stem diameter ED S , to permit a slip fit of the body 22 over the stem 142.
- the intermediate main body region 148 has an enlarged exterior diameter selected for the collapsed geometry of the body 22. To preserve the desired wall thickness, the enlarged exterior diameter of the tube 140 should be about twice the original extruded outer diameter of the tube 140.
- FIG. 15C shows, the tubing ends 150 extending beyond the neck regions 144 and 146 are cut away.
- Fig. 15D shows, the body 22 is slip fitted over the stem 142. Heat is applied to shrink fit the neck regions 144 and 146 about the stem 142 (see Fig. 15E) . Due to molding, the memory of these regions 144 and 146, when heated, seek the original interior diameter ID, of the tubing 140, thereby proving a secure interference fit about the stem 142.
- the sleeve 78 is heat-shrunk in place about the proximal neck region 144 (see Fig. 15E) .
- the sleeve 78 can comprise a heat-shrink plastic material or phase changeable metal material, like nickel titanium.
- the sleeve 78 can be heat-shrunk into place without an intermediate thermal fusing step.
- Figs. 16A to 16D show the details of a preferred assembly process for an expandable-collapsible body 22 whose geometry is altered by use of an interior support structure 44 of spline elements 46, such as previously shown in Figs. 4 and 5.
- the distal neck region 146 is secured by heat shrinking about the distal fixture 66 (see Fig. 16A) .
- the distal fixture 66 has, preattached to it, the distal end of the spline element structure 44, as well as any desired steering mechanism 54, stilette 76, or combination thereof (not shown in Figs. 16A to 16D) .
- the main region 148 of the body 22 is oriented in a direction opposite to the spline element structure 44.
- the body 22 is everted about the distal fixture 66 over the spline element structure 44 (see Fig. 16B) .
- the proximal end of the spline element structure 44 is secured to an anchor 156 carried by the distal catheter end 16 (see Fig. 16C) , and the everted proximal neck region 144 is then slip fitted over the catheter stem 158.
- the catheter stem 158 in this arrangement does not extend beyond the neck region 144 of the body 22. Heat is then applied to shrink fit the neck region 144 about the stem 158 (see Fig. 16D) .
- the sleeve 78 is heat-shrunk in place about the proximal neck region 144.
- the sleeve 78 can be heat- shrunk into place without an intermediate thermal fusing step.
- the purpose of the electrically conducting shell 24 is to transmit ablation energy, which in the illustrated and preferred embodiment comprises electromagnetic radio frequency energy with a frequency below about 1.0 GHz. This type of ablating energy heats tissue, mostly ohmically, to form lesions without electrically stimulating it.
- the shell 24 should possess the characteristics of both high electrical conductivity and high thermal conductivity. It should also be appreciated that the shell 24 could form an antenna for the transmission of higher frequency microwave energy.
- the electrode structure 20 is able to create lesions of different size and geometries.
- the shell creates lesion patterns greater than about 1.5 cm deep and/or about 2.0 cm wide. These lesion patterns are significantly deeper and wider than those created by conventional 8F diameter/4 mm long electrodes, which are approximately 0.5 cm deep and 10 mm wide.
- the deeper and wider lesion patterns that the shell 24 can provide are able to destroy epicardial and intramural ventricular tachycardia (VT) substrates.
- VT epicardial and intramural ventricular tachycardia
- Finite element analysis was performed for a flexible, expanded electrode structure 20 having a 1.4 cm diameter and a wall thickness of approximately 200 ⁇ m.
- the model assumed a 100 ⁇ m thick coating of gold over the distal hemisphere of the structure 20, forming the electrically conductive shell 24.
- the constraint for the model was a lower limit on thickness and therefore the thermal conductivity of the shell 24.
- the percent of electrically conductive shell 24 in contact with myocardial tissue, with the balance exposed to blood was changed from 5%, 20%, 41%, and 100% tissue contact. Time and power of energy transmission were also varied. Power was changed to keep the maximum temperature of tissue under the shell 24 at 90° C. Maximum lesion depth, width, and volume were measure .
- the lesions created in the above Table 1 are capable of making transmural lesions in the left ventricle and can therefore ablate epicardial VT substrates.
- the Table 1 shows that lesion size increases with an electrically conductive shell 24 presenting less percentage contact with tissue than blood.
- the shell presenting 100% contact with tissue (and none with blood) compared to the shell 24 presenting up to 41% percent of its surface to tissue had lower lesion depths.
- the shell 24 With less relative contact with tissue than blood, the shell 24 is more exposed to the blood pool and its convective cooling effect.
- the blood cools the shell 24 it contacts. Heat is lost from tissue under the shell 24 into the blood pool. This emulation of active cooling of the shell 24 causes more power to be transmitted to the tissue before maximum tissue temperatures are achieved, thereby creating larger lesions.
- Table 1 highlights the importance of relatively high thermal conductivity for the shell 24, which can be achieved by material selection and controlling thickness. Given the same percentage contact with tissue versus blood, a higher thermal conductivity results in a higher cooling effect and a corresponding increase in lesion size.
- Table 1 demonstrates the ability of the structure 20 carrying the shell 24 to transmit the proper amount of radio frequency energy to create large and deep lesions.
- Table 2 demonstrates the ability of the structure carrying the shell 24 to transmit the proper amount of radio frequency energy to create wide and shallow lesions. The effect is achieved by controlling both the delivered radio frequency power and the time of radio frequency energy application. Wide and shallow lesion patterns are effective in the treatment of some endocardially located substrates and atrial fibrillation substrates.
- Tables 1 and 2 demonstrate the capability of the same expandable-collapsible electrode structure 20 with the desirable lower percentage contact with tissue relative to blood (less than 50%) to ablate epicardial, intramural, or endocardial substrates with a range of lesion patterns from wide and shallow to large and deep.
- the electrically conductive shell 24 may be deposited upon the exterior of the formed expandable-collapsible body 22.
- a mask is placed upon the surface of the expandable-collapsible body 22 that is to be free of the shell 24.
- the shell 24 is not deposited on at least the proximal l/3rd surface of the expandable-collapsible body 22. This requires that at least the proximal l/3rd surface of the expandable-collapsible body 22 be masked, so that no electrically conductive material is deposited there.
- the masking of the at least proximal l/3rd surface of the expandable-collapsible body 22 is desirable for several reasons. This region is not normally in contact with tissue, so the presence of electrically conductive material serves no purpose. Furthermore, this region also presents the smallest diameter. If electrically conductive, this region would possess the greatest current density, which is not desirable. Masking the proximal region of smallest diameter, which is usually free of tissue contact, assures that the maximum current density will be distributed at or near the distal region of the expandable-collapsible body 22, which will be in tissue contact. The presence of the steering mechanism 54, already described, also aids in placing the shell-carrying distal tip in tissue contact.
- the shell 24 comprises a material having a relatively high electrical conductivity, as well as a relative high thermal conductivity. Materials possessing these characteristics include gold, platinum, platinum/iridium, among others. These materials are preferably deposited upon the unmasked, distal region of the expandable- collapsible body 22. Usable deposition processes include sputtering, vapor deposition, ion beam deposition, electroplating over a deposited seed layer, or a combination of these processes.
- an undercoating 80 is first deposited on the unmasked distal region before depositing the shell 24.
- Materials well suited for the undercoating 80 include titanium, iridium, and nickel, or combinations or alloys thereof.
- the total thickness of the shell 24 deposition, including the undercoating 80, can vary. Increasing the thickness increases the current-carrying and thermal conductive capacity of the shell 24. However, increasing the thickness also increases the potential of shell cracking or peeling during enlargement or collapse of the underlying expandable-collapsible body 22.
- the deposition of the electrically conductive shell material should normally have a thickness of between about 5 ⁇ m and about 50 ⁇ m.
- the deposition of the adherence undercoating 80 should normally have a thickness of about 1 ⁇ m to about 5 ⁇ m.
- C. Foil Shell Surface In an alternative embodiment (see Fig. 18) , the shell 24 comprises a thin sheet or foil 82 of electrically conductive metal affixed to the wall of the expandable-collapsible body 22.
- Materials suitable for the foil include platinum, platinum/iridium, stainless steel, gold, or combinations or alloys of these materials.
- the foil 82 is shaped into a predetermined geometry matching the geometry of the expandable-collapsible body 22, when expanded, where the foil 82 is to be affixed.
- the geometry of the metal foil 82 can be accomplished using cold forming or deep drawing techniques.
- the foil 82 preferably has a thickness of less than about .005 cm (50 ⁇ m) .
- the foil 82 is affixed to the expandable-collapsible body 22 using an electrically insulating epoxy, adhesive, or the like.
- the shell 24 of foil 82 offers advantages over the deposited shell 24. For example, adherence of the shell foil 82 upon the expandable-collapsible body 22 can be achieved without using the deposited undercoating 80.
- the shell foil 82 also aids in the direct connection of ablation energy wires 26, without the use of additional connection pads and the like, as will be described in greater detail later.
- the shell foil 82 also offers greater resistance to stretching and cracking in response to expansion and collapse of the underlying expandable- collapsible body 22. This offers greater control over resistance levels along the ablation energy transmitting surface.
- the extra external shell 24 can be eliminated, if the coextruded body 22 itself possesses the desired electrical and thermal conductive characteristics.
- the integral electrically conducting material 84 coextruded into the body 22 offers certain advantages over the external deposited shell 24 (Fig. 17) or shell foil 82 (Fig. 18) . Coextrusion avoids the necessity of adherence between the shell 24 and the expandable-collapsible body 22.
- a body 22 coextruded with electrically conducting material 84 also permits more direct connection of ablation energy wires 34, without the use of additional connection pads and the like.
- the integrated nature of the coextruded material 84 in the body 22 protects against cracking of the ablation energy transmitting surface during expansion and collapse of the expandable-collapsible body 22.
- the integral electrically conducting material 84 coextruded into the body 22 also permits the creation of a family of electrode structures 20, with the structures 20 differing in the amount of conductive material 84 coextruded into the wall of the respective body 22.
- the amount of electrically conductive material coextruded into a given body 22 affects the electrical conductivity, and thus the electrical resistivity of the body 22, which varies inversely with conductivity. Addition of more electrically conductive material increases electrical conductivity of the body 22, thereby reducing electrical resistivity of the body 22, and vice versa. It is thereby possible to specify among the family of structures 20 having electrically conductive bodies 22, the use of a given structure 20 according to a function that correlates desired lesion characteristics with the electrical resistivity values of the associated body 22.
- EXAMPLE 2 A three-dimensional finite element model was created for an electrode structure having a body with an elongated shape, with a total length of 28.4 mm, a diameter of 6.4 mm, and a body wall thickness of .1 mm.
- the body of the structure was modeled as an electric conductor.
- Firm contact with cardiac tissue was assumed along the entire length of the electrode body lying in a plane beneath the electrode.
- Contact with blood was assumed along the entire length of the electrode body lying in a plane above the electrode.
- the blood and tissue regions had resistivities of 150 and 500 ohm*cm, respectively.
- Table 3 shows the depth of the maximum tissue temperature when RF ablation power is applied to the electrode at various power levels and at various levels of resistivity for the body of the electrode.
- the electrode body with higher resistivity body was observed to generate more uniform temperature profiles, compared to a electrode body having the lower resistivity value. Due to additional heating generated at the tissue-electrode body interface with increased electrode body resistivity, less power was required to reach same maximal temperature. The consequence was that the lesion depth decreased.
- the shell 24 should, of course, be oriented about the distal tip of the expandable- collapsible body 22.
- the shell 24 may comprise a continuous cap deposited upon the distal l/3rd to 1/2 of the body 22, as Fig. 17 shows.
- the preferred embodiment segments the electrically conductive shell 24 into separate energy transmission zones 122 arranged in a concentric "bull's-eye" pattern about the distal tip of the body 22.
- the concentric bull's-eye zones 122 are formed by masking axially spaced bands on the distal region of the body 22, to thereby segment the deposit of the electrically conductive shell 24 into the concentric zones 122.
- preformed foil shells 82 can be applied in axially spaced bands on the distal region to form the segmented energy transmitting zones 122.
- the shell 24 is preferably segmented into axially elongated energy transmission zones 122, which are circumferentially spaced about the distal l/3rd to 1/2 of the body 22 (see Figs. 21 and 22) .
- the circumferentially spaced zones 122 are formed by masking circumferentially spaced areas of the distal region of the body 22, to thereby segment the deposit of the electrically conductive shell 24 into the zones 122.
- preformed foil shells 82 can be applied in circumferentially spaced-apart relationship on the distal region to form the segmented energy transmitting zones 122.
- the circumferentially segmented energy transmission zones 122 may take the form of semi-rigid pads carried by the expandable- collapsible body 22. Adjacent pads overlap each other when the body 22 is in its collapsed geometry. As the body 22 assumes its expanded geometry, the pads spread apart in a circumferential pattern on the body 22.
- each energy transmission zone 122 is coupled to a dedicated signal wire 26 or a dedicated set of signal wires 26. This will be described later in greater detail.
- the controller 32 can direct ablation energy differently to each zone 122 according to prescribed criteria, as will also be described in greater detail later.
- the interior surface of the body 22 can carry electrodes 402 suitable for unipolar or bipolar sensing or pacing. Different electrode placements can be used for unipolar or bipolar sensing or pacing. For example, pairs of 2-mm length and 1-mm width electrodes 402 can be deposited on the interior surface of the body 22. Connection wires 404 can be attached to these electrodes 100. Preferably the interelectrode distance is about 1 mm to insure good quality bipolar electrogra s. Preferred placements of these interior electrodes are at the distal tip and center of the body 22. Also, when multiple zones are used, it is desired to have the electrodes 402 placed in between the ablation regions.
- opaque markers 406 are on the interior surface of the body 22 so that the physician can guide the device under fluoroscopy to the targeted site.
- Any high-atomic weight material is suitable for this purpose.
- platinum, platinum-iridiu . can be used to build the markers 406. Preferred placements of these markers 106 are at the distal tip and center of the structure 22.
- segmented energy transmitting zones 122 are well suited for use in association with folding expandable-collapsible bodies 22, as previously described in connection with Figs. llA/B/C.
- the regions that are masked before deposition of the electrical conductive shell comprise the folding regions 52.
- the regions 52 of the expandable- collapsible body 22 that are subject to folding and collapse are those that do not carry an electrically conductive shell 24.
- the electrically conductive shell 24 is thereby protected against folding and stretching forces, which would cause creasing and current interruptions, or increases in resistance, thereby affecting local current densities and temperature conditions.
- the selective deposition of the shell 24 in segmented patterns can itself establish predefined fold lines 52 on the body 22, without special molding of preformed regions of the body 22 (as Figs. 11A/B/C contemplate) .
- predefined fold lines 52 can be created at the boarders between the shell segments 122. These fold lines 52 are created due to the difference in thickness between adjacent regions which are coated with the shell 24 and those which are not.
- the region between segmented shell coatings will establish a fold line 52, when the distance between the coatings (designated x in Figs. 24A and B) is greater than or equal to twice the thickness of the adjacent shell coatings 122 (designated t in Figs. 24A and B) divided by the tangent of one half the minimum selected fold angle (designated ⁇ M
- This fold line relationship is mathematically expressed as follows:
- the minimum selected fold angle 2 ⁇ MIN can vary according to the profile of the body 22 desired when in the collapsed geometry.
- the minimum fold angle 2 ⁇ HIN is in the range of 1° to 5°.
- the fold lines 52 created by controlled deposition of shell segments lie uniformly along (i.e., parallel to) the long axis of the body 22 (designated 170 in Fig. 23) .
- the uncoated fold lines 52 created at the boarders between the thicker coated shell segments 122 can also be characterized in terms of relative electrical resistivity values.
- the coated segments 122 of electrically conductive material possess higher electrical conductivity than the uncoated fold lines 52.
- the resistivity of the fold lines 52 which varies inversely with conductivity, is thereby higher than the resistivity of the segments 122.
- the region in which folding occurs should have a resistivity that is greater than about ten times the resistivity of the segments 122 carrying electrically conductive material.
- IV. Electrical Connection to Shell It is necessary to electrically connect the shell 24 (or other ablation energy transmitting material 84) to the radio frequency energy generator 30 using the one or more signal wires 26. As before described, these signal wires 26, electrically connected to the shell 24, extend between the body 22 and the external connectors 28 through the catheter tube 12.
- connection between the signal wires 26 and the shell 24, whether deposited, foil layered, or coextruded, must remain intact and free of open circuits as the expandable-collapsible body 22 and shell 24 change geometries.
- the electrical connection is preferably oriented proximate to the geometric center of the pattern that the associated ablation zone 122 defines.
- the geometric center (designated GC) varies depending upon whether the zone 122 comprises a cap pattern (as Fig. 25 shows) , or a circumferential segment pattern (as Fig. 26 shows) , or a circumferential band or bull's-eye pattern (as Fig. 27 shows) .
- At least one electrical connection should be present proximate to the respective geometric center of the pattern. This ensures that maximum current density is distributed about the geometric center of the zone and that similar current densities are distributed at the edges of the pattern.
- additional electrical connections are preferably made in each ablation zone.
- the additional electrical connections (designated AC in, respectively, Figs. 25 and 26) are distributed uniformly about the geometric center.
- the additional electrical connections are distributed uniformly along the arc along which the geometric center of the band lies.
- multiple signal wires 26 are lead through the interior of the body 22 and out through a center aperture 74 in the distal fixture 66.
- Multiple signal wires 26 are preferred, as multiple electrical connections provide a more uniform current density distribution on the shell 24 than a single connection.
- the signal wires 26 are enclosed within electrical insulation 160 (see Fig. 28B) except for their distal ends. There, the electrical insulation 160 is removed to exposed the electrical conductor 162.
- the exposed electrical conductor 162 is also preferably flattened by mechanical means to provide an increased surface area.
- the flattened conductors 162 are affixed by an electrically conductive adhesive proximate to the geometric center and elsewhere at additional uniformly spaced intervals about it on the cap pattern, as well as along the geometric center of the concentric bands of the bull's-eye pattern, which the shell 24, when deposited, will create. It is preferred that the adhesive connections of the conductors 162 to the body 22 be positioned, when possible, relatively close to an established support area on body 22, such as provided by the distal fixture 66. The support that the fixture 66 provides a more secure attachment area for the electrical connections.
- the shell 24 is deposited in the desired pattern on the body 22, over the adhesively attached conductors 162, in a manner previously described.
- the center aperture 74 in the distal fixture 66 is sealed closed by adhesive or equivalent material.
- the distal fixture 66 can also be used to create a mechanical connection to electrically couple a single signal wire 26 to the geometric center of the cap of the bull's-eye pattern.
- the fixture 66 is made from an electrically conductive material.
- the signal wire 26 is connected by spot welding, soldering, or electrically conductive adhesive to the fixture 66 within the expandable- collapsible body 22.
- a nut 74 engaging a threaded fixture end 164 sandwiches the distal tip of the body 22 between it and the collar 68 (see Fig. 29B) .
- Epoxy which could be electrically conductive, could be used to further strengthen the mechanical connection between the nut 74 and the body 22 sandwiched beneath it.
- the shell 24 is next deposited on the body 22 and nut 74 in a manner previously described.
- the shell 24 can be deposited on the body 22 before attachment of the nut 74.
- the nut 74 sandwiches the shell 24 between it and the collar 68, mechanically establishing the desired electrical connection between the signal wire 26 and the shell 24.
- a heat shrunk slip ring of nickel titanium material can be used instead of a threaded nut connection.
- any riveting, swagging, electrically conductive plating, or bonding technique can be used to hold the shall 24 in contact against the collar 68.
- insulated signal wires 26 passed into the interior of the body can be snaked through the body 22 at the desired point of electrical connection.
- the electrical insulation 160 of the distal end of the snaked-through wire 26 is removed to exposed the electrical conductor 162, which is also preferably flattened.
- the flattened conductors 162 are affixed by an electrically conductive adhesive 172 to body 22, over which the shell 24 is deposited.
- Adhesive 172 is also preferable applied in the region of the body 22 where the wire 26 passes to seal it. As Fig. 31 shows, the same signal wire 26 can be snaked through the body 22 multiple times to establish multiple electrical connections within the same ablation zone.
- the expandable-collapsible body 22 can be formed as a laminate structure 90.
- the laminate structure 90 comprises a base layer 92, formed from an electrically insulating material which peripherally surrounds the interior of the body 22.
- the laminate structure 90 further includes one or more intermediate layers 94 formed on the base layer 92.
- An ablation energy wire 26 passes through each intermediate layer 94.
- Each intermediate layer 94 is itself bounded by a layer 96 of electrically insulating material, so that the wires 26 are electrically insulated from each other.
- the laminate structure 90 also includes an outer layer 98 which is likewise formed from an electrically insulating material.
- the laminate structure 90 can be formed by successively dipping a mold having the desired geometry in a substrate solution of electrically insulating material.
- the ablation energy wires 26 are placed on substrate layers between successive dippings, held in place by electrically conductive adhesive or the like.
- one or more windows 100 are opened through the outer insulation layer 98 in the region which the electrically conductive shell 24 will occupy.
- Each window 100 exposes an ablation energy signal wire 26 in a chosen layer.
- Various windowing techniques can be employed for this purpose. For example, C0 2 laser, Eximer laser, YAG laser, high power YAG laser, or other heating techniques can be used to remove insulation to the desired layer and thereby expose the desired signal wire 26.
- the formed expandable- collapsible body 22 is masked, as before described.
- the shell 24 of electrically conductive material is deposited over the unmasked area, including the windows 100, which have been previously opened.
- the deposited shell 24 enters the windows 100, making electrically conductive contact with the exposed wires 26.
- a plating or other deposition process may be used in the window 100, before depositing the electrically conductive shell 24.
- the plating fills in the window 100 to assure good electrical contact with the over-deposit of shell 24.
- Fig. 3D shows an alternative equivalent laminated structure, in which the chamber 124 occupies the interior of the body 22. This creates a multiple layer structure equivalent to the laminated structure just described.
- An open intermediate layer 126 exists between the interior of the body 22 and the exterior of the chamber 124, through which signal wires 26 can be passed for electrical connection to the shell 24.
- the electrical connection can be made using either a distal fixture 66 or by snaking the wires through the exterior body 22 (as Fig. 3D shows) , both of which have already been described.
- a controller 32 preferably governs the conveyance of radio frequency ablation energy from the generator 30 to the shell 24.
- the collapsible electrode structure 20 carries one or more temperature sensing elements 104, which are coupled to the controller 32. Temperatures sensed by the temperature sensing elements 104 are processed by the controller 32. Based upon temperature input, the controller adjusts the time and power level of radio frequency energy transmissions by the shell 24, to achieve the desired lesion patterns and other ablation objectives.
- the temperature sensing elements 104 can take the form of thermistors, thermocouples, or the equivalent.
- a temperature sensing element 104 may be located within the distal fixture 66 to sense temperature at the distal tip, as Fig. 33 shows.
- multiple temperature sensing elements may be scattered at spaced apart locations on the shell 24 or expandable-collapsible body 22, as Fig. 34 shows.
- the connection of temperature sensing elements 104 to the shell 24 or expandable-collapsible body 22 can be achieved in various ways. As shown in Fig. 34, when the expandable- collapsible body 22 comprises a thermal conductive material, the temperature sensing element (designated 104A in Fig. 34) can be attached to the interior surface of the body 22 in the region where measurement of exterior surface temperature is desired. A thermally conductive, but electrically insulating adhesive 106 can be used to secure the temperature sensing element 104A to the inside of the body 22.
- the temperature sensing element wires 110 extend through the catheter tube 12 for coupling (using a suitable connector 28, shown in Fig. l)to the controller 32.
- the temperature sensing element (designated 104B and 104C in Fig. 34) can be attached to the exterior surface of the body 22 in the region where measurement of temperatures is desired.
- a thermally conductive, but electrically insulating adhesive 106 can be used to secure the temperature sensing element to the outside of the body 22.
- the electrically conductive shell 24 can be deposited over the temperature sensing element 104B, in the manner previously described. In this way, the temperature sensing element 104B resides under the electrically conductive shell 24, and no discontinuities in the shell 24 are present.
- the element 104C can be masked at the time the electrically conductive shell 24 is deposited. In this arrangement, there is no electrically conductive material over the temperature sensing element 104C.
- the signal wires 110 attached to the temperature sensing element 104C can be attached by electrically insulating adhesive to the outside the expandable- collapsible body 22.
- the signal wires 110 can be brought from the interior of the expandable-collapsible body 22 through the expandable-collapsible body 22 for attachment by a thermally conductive, but electrically insulating adhesive 106 to the outside of the body 22.
- the same type of adhesive 106 can also be used to anchor in signal wires 110 to the inside of the expandable-collapsible body 22.
- thermocouples 112 may also be integrally formed by deposition on the expandable-collapsible body.
- the body 22 comprises a laminated structure 114, like that previously shown in Fig. 31, comprising a base layer 92, an outer layer 98, and one or more intermediate layers 94.
- the intermediate layers 94 formed in this structure thermocouple wires 116 (t- type or other combinations) .
- windowing of the laminated expandable-collapsible body 116 in the manner previously described exposes the thermocouple wires.
- thermocouple 112A shows in Fig. 35, the thermocouple 112A can be masked at the time the electrically conductive shell 24 is deposited. In this arrangement, there is no electrically conductive material over the thermocouple 112A.
- Figs. 20 and 21A/B show multiple temperature sensing elements 104 are located on and about the shell 24 to ascertain temperature conditions during radio frequency energy ablation.
- the controller 32 uses temperature information from temperature sensing elements to control the transmission of ablation energy by the shell 24.
- at least one temperature sensing element 104 is preferably placed proximal to the geometric center of the energy transmitting shell 24.
- at least one temperature sensing element 104 should be proximal to the geometric center of each energy transmitting segment 122.
- temperature sensing elements 104 are also placed along the edges of the shell 24, where it adjoins a masked, electrically non-conductive region of the body 22.
- temperature sensing elements 104 should be placed along the edge of each energy transmitting segment 122. High current densities occur along these regions where energy transmitting material adjoins non-energy transmitting material. These edge effects lead to higher temperatures at the edges than elsewhere on the shell 24. Placing temperature sensing elements 104 along the edges assures that the hottest temperature conditions are sensed.
- a shell 24 segmented into adjacent energy transmitting zones 122 it is also desirable to place at least one temperature sensing element 104 between adjacent energy transmitting zones, as Figs. 20 and 21A/B show. Placing multiple temperature sensing elements 104 in the segments 122, between the segments 122, and along the edges of the segments 122 allows the controller 32 to best govern power distribution to the multiple segments 122 based upon predictions of hottest temperature conditions. Further details of the use of multiple temperature sensing elements, including edge temperature sensing elements, and the use of temperature prediction methodologies, are found in copending U.S. Patent Application Serial No. 08/439, 824, filed May 12, 1995, and entitled "Systems and Methods for Controlling Tissue Ablation Using Multiple Temperature Sensing Elements.”
- segmented energy transmission zones 122 each with its own prescribed placement of temperature sensing elements 104, allows the controller 32 to govern the delivery of power to each zone 122 separately.
- the controller 32 is thereby able to take into account and react to differences in convective cooling effects in each zone 122 due to blood flow, differences in contact pressure and surface area between each zone 122 and the tissue its contacts, and other nonlinear factors affecting the power required to heat tissue adjacent each zone 122 to a predetermined temperature to achieve the desired lesion geometry and pattern.
- any given transmission zone like the continuous, non-segmented shell 24 shown in Fig. 25 or each segmented zone 122 shown in Figs. 26 and 27
- it is desirable to allow some contact with the blood pool to allow beneficial convective cooling effects it is not desirable that any given zone contact only or substantially only the blood pool. Loss of power into the blood pool with no tissue ablation effects occurs.
- segmented zones 122 it is possible to sense, using the temperature sensing elements 104, where insubstantial tissue contact exists. It is thereby possible to sense and to channel available power only to those zones 122 where substantial tissue contact exists. Further details of tissue ablation using segmented electrode structures are disclosed in copending U.S. Patent Application Serial No. 08/139,304, filed October 19, 1993 and entitled "Systems and Methods for Creating Lesions in Body Tissue Using Segmented Electrode Assemblies.”
- Fig. 36 shows a referred representative embodiment when the shell 4 comprises a continuous cap pattern.
- the structure 20 carries five temperature £ ⁇ sing elements 104 spaced apart on the shell 24.
- the temperature sensing elements 104 are connected in a selected one or more of the manners previously described.
- sensing elements Tn, and Tp are placed at diametrically opposite regions at the most proximal edge of the shell 24.
- Sensing elements Tm, and Tm j are placed at diametrical sides of the middle region of the shell 24, for example, at about 50% of the radius of the structure.
- the sensor Tc is placed proximal the geometric center of the shell 24. All temperature sensors are coupled to a temperature controller, which processes information from the sensors.
- the temperature controller 32 infers the percentage of tissue contact with the shell 24 contact based upon where significant increases in temperature conditions from an established baseline level (for example, 37° C) are sensed on the shell 24. These increased temperature conditions indicate the absence of convective cooling effects, as would occur with contact with the blood pool, thereby suggesting tissue contact. As the preceding Tables 1 and 2 show, percentage of contact between the shell 24 and tissue dictate effective power levels to achieve the type of lesion desired.
- the relationship between percentage shell-tissue contact and power desired for a given lesion characteristic can be based upon empirical or theoretical data in the manner set forth in the preceding Example. These relationships can be set forth in look up table format or incorporated in equivalent decision matrices, which the controller 32 retains in memory.
- significant increase in temperature above the baseline at Tc, but not elsewhere indicates a 20% tissue contact condition, and a first power level is commanded for the generator 30 based upon the selected power criteria.
- Significant increase in temperature above the baseline also at Tm, and Tm indicates a 50% tissue contact condition, and second power level less than the first is commanded for the generator 30 based upon the selected power criteria.
- Significant increase in temperature above the baseline also at Tn, and Tn 2 indicates a 100% tissue contact condition, and third power level less than the second is commanded based upon the selected power criteria.
- Fig. 37 shows a preferred representative embodiment when the shell 24 comprises a circumferentially spaced, segmented pattern.
- the structure 20 carries at least four temperature sensing elements on each shell segment.
- the sensor Tc is common to all segments and is located at the distal end of the pattern.
- the sensor T y . is located at the geometric center of each segment, while the sensors T E , and T ⁇ are located along opposite edges of each segment, where the shell 24 adjoins the non-electrically conductive regions separating the segments.
- An additional sensor T M is preferably also located generally between the segments for the reasons discussed before.
- Fig. 38 shows a preferred representative embodiment when the shell 24 comprises a bull's-eye pattern.
- Sensors T GC are located at the geometric center of each segment of the pattern, while the sensors T E , and T E2 are located along opposite edges of each segment, where the shell 24 adjoins the non- electrically conductive regions separating the segments.
- An additional sensor T H is preferably also located generally between the segments for the reasons discussed before. VI. Active Cooling
- the capability of the shell 24 to form large lesions can be enhanced by actively cooling the shell 24 while transmitting ablation energy.
- Active cooling can be accomplished by the use of multiple lumens to cycle a cooled fluid through the expandable-collapsible body 22 while transmitting ablation energy.
- a high pressure gas can be transported by the lumens for expansion within the expandable-collapsible body to achieve a comparable active cooling effect.
- the cooled medium can be conveyed outside the expandable-collapsible body 22 to achieve an active cooling effect.
- a pattern of small holes 174 is created in the region between segmented shell patterns 122.
- Liquid cooling medium is perfused from inside the body 22 through the holes 174 to provide localized cooling adjacent the edges of the shell segments 122. It should be appreciated that hole patterns 174 could be used elsewhere on the body 22 to provide active cooling effects.
- the selective establishment of hole patterns 174 on the body 22 can also itself establish predefined fold lines 52, eliminating the need to specially mold preformed folding regions the body 22.
- the pattern of small holes 174 create fold lines 52 by the removal of material, thereby increasing the flexibility of the body 22 along the holes 174 between adjacent regions 122.
- the fold lines 52 created by hole patterns 174 lie uniformly along (i.e., parallel to) the long axis of the body 22.
- the same expandable-collapsible electrode structure 20 is able to selectively form lesions that are either wide and shallow or large and deep.
- Various methodologies can be used to control the application of radio frequency energy to the shell 24 of the body 20 to achieve this result.
- the controller 32 includes an input 300 for receiving from the physician a desired therapeutic result in terms of (i) the extent to which the desired lesion should extend beneath the tissue-electrode interface to a boundary depth between viable and nonviable tissue and/or (ii) a maximum tissue temperature developed within the lesion between the tissue-electrode interface and the boundary depth.
- the controller 32 also includes a processing element 302, which retains a function that correlates an observed relationship among lesion boundary depth, ablation power level, ablation time, actual or predicted sub-surface tissue temperature, and electrode temperature.
- the processing element 302 compares the desired therapeutic result to the function and selects an operating condition based upon the comparison to achieve the desired therapeutic result without exceeding a prescribed actual or predicted sub-surface tissue temperature.
- the operating condition selected by the processing element 302 can control various aspects of the ablation procedure, such as controlling the ablation power level, the rate at which the structure 20 is actively cooled, limiting the ablation time to a selected targeted ablation time, limiting the ablation power level subject to a prescribed maximum ablation power level, and/or the orientation of the shell 24, including prescribing a desired percentage contact between the shell 24 and tissue.
- the processing element 302 can rely upon temperature sensors carried by or otherwise associated with the expandable-collapsible structure 20 that penetrate the tissue to sense actual maximum tissue temperature. Alternatively, the processing element 302 can predict maximum tissue temperature based upon operating conditions.
- the electrode structure 20 carries at least one temperature sensing element 104 to senses instantaneous localized temperatures (Tl) of the thermal mass of the shell 24.
- Tl instantaneous localized temperatures
- the temperature Tl at any given time is a function of the power supplied to the shell 24 by the generator 30 and the rate at which the shell 24 is cooled, either by convective cooling by the blood pool, or active cooling by another cooling medium brought into contact with the shell 24, or both.
- the characteristic of a lesion can be expressed in terms of the depth below the tissue surface of the 50° C isothermal region, which will be called D 50c .
- the depth l oc is a function of the physical characteristics of the shell 24 (that is, its electrical and thermal conductivities and size) ; the percentage of contact between the tissue and the shell 24; the localized temperature Tl of the thermal mass of the shell 24; the magnitude of RF power (P) transmitted by the shell 24 into the tissue, and the time (t) the tissue is exposed to the RF power.
- the maximum temperature condition TMAX lies within a range of temperatures which are high enough to provide deep and wide lesions (typically between about 85° C and 95° C) , but which are safely below about 100° C, at which tissue desiccation or tissue micro-explosions are known to occur. It is recognized that TMAX will occur a distance below the electrode-tissue interface between the interface and
- the maximum power level PMAX takes into account the physical characteristics of the electrode and the power generation capacity of the RF generator 30.
- the D50C function for a given shell 24 can be expressed in terms of a matrix listing all or some of the foregoing values and their relationship derived from empirical data and/or computer modeling.
- the physician also uses the input 300 to identify the characteristics of the structure 20, using a prescribed identification code; set a desired maximum RF power level PMAX; a desired time t; and a desired maximum tissue temperature TMAX.
- the processing element 302 compares the desired therapeutic result to the function defined in the matrix (as exemplified by the above Tables 1 and 2) .
- the master controller 58 selects an operating condition to achieve the desired therapeutic result without exceeding the prescribed TMAX by controlling the function variables.
- This arrangement thereby permits the physician, in effect, to "dial-a-lesion" by specifying a desired D 50c .
- the processing element can achieves the desired D 50c without the need to sense actual tissue temperature conditions.
- the structure 20 is cooled either by convective blood flow (depending upon percentage contact between the shell 24 and tissue) , or by actively using another cooling medium, or both.
- the level of RF power delivered to the cooled structure 20 and/or the cooling rate can be adjusted based upon a prediction of instantaneous maximum tissue temperature, which is designated T MA ⁇ (t) .
- the prediction of T NA ⁇ is derived by a neural network, which has as inputs a prescribed number of previous power levels, previous rates at which heat has been removed to cool the structure 20, and previous shell temperature.
- c is the heat capacity of the cooling medium used (in Joules (J) per kilogram (kg) Kelvin (K) , or J/kg K)
- ⁇ T is the temperature drop in the cooling medium during passing through the structure 20 (K)
- RATE is the mass flow rate of the cooling medium through the structure (kg/sec) .
- the heat generated by the structure 20 into the tissue is the difference between the heat generated by Joule effect and the heat removed by cooling.
- Tl and A represent an indirect measurement of how rapidly the sub-surface tissue temperature is changing.
- Tl and A are therefore predictive of the depth and magnitude of the hottest sub-surface tissue temperature T MA ⁇ , and thus indirectly predictive of the lesion boundary depth D 50c .
- the generator 30 is conditioned through an appropriated power switch interface to deliver RF power in multiple pulses of duty cycle 1/N.
- AMP E(J) is the amplitude of the RF voltage conveyed to the electrode region E(J)
- DUTYCYCLE E(J) is the duty cycle of the pulse, expressed as follows: DUTYCYCLE ⁇ T0N E E U iJ ) £ TON E ⁇ J) + TOFF E [J) where :
- TON E(J) is the time that the electrode region E(J) emits energy during each pulse period
- TOFF E(J) is the time that the electrode region E(J) does not emit energy during each pulse period.
- TON E(J) + TOFF E(J) represents the period of the pulse for each electrode region E(J) .
- the generator 30 can collectively establish duty cycle (DUTYCYCLE E(J) ) of 1/N for each electrode region (N being equal to the number of electrode regions) .
- the generator 30 may sequence successive power pulses to adjacent electrode regions so that the end of the duty cycle for the preceding pulse overlaps slightly with the beginning of the duty cycle for the next pulse. This overlap in pulse duty cycles assures that the generator 30 applies power continuously, with no periods of interruption caused by open circuits during pulse switching between successive electrode regions.
- the temperature controller 32 makes individual adjustments to the amplitude of the RF voltage for each electrode region (AMP E(J) ) , thereby individually changing the power P E(J) of ablating energy conveyed during the duty cycle to each electrode region, as controlled by the generator 30.
- the generator 30 cycles in successive data acquisition sample periods. During each sample period, the generator 30 selects individual sensors S(J,K), and temperature codes
- TEMP(J) (highest of S(J,K)) sensed by the sensing elements 104, as outputted by the controller 32.
- the controller 32 registers all sensed temperatures for the given electrode region and selects among these the highest sensed temperature, which constitutes TEMP(J).
- the generator 30 compares the temperature TEMP(J) locally sensed at each electrode E(J) during each data acquisition period to a set point temperature TEMP SET established by the physician. Based upon this comparison, the generator 30 varies the amplitude AMP E(J) of the RF voltage delivered to the electrode region E(J) , while maintaining the DUTYCYCLE ⁇ jj for that electrode region and all other electrode regions, to establish and maintain TEMP(J) at the set point temperature TEMP s ⁇ .
- the set point temperature TEMP SET can vary according to the judgment of the physician and empirical data. A representative set point temperature for cardiac ablation is believed to lie in the range of 40°C to 95 C, with 7*0 C being a representative preferred value.
- the manner in which the generator 30 governs AMP E(J) can incorporate proportional control methods, proportional integral derivative (PID) control methods, or fuzzy logic control methods. For example, using proportional control methods, if the temperature sensed by the first sensing element TEMP(l) > TEMP SET , the control signal generated by the generator 30 individually reduces the amplitude AMP E(1) of the RF voltage applied to the first electrode region E(l) , while keeping the duty cycle DUTYCYCLE E ⁇ 1) for the first electrode region E(l) the same.
- proportional control methods if the temperature sensed by the first sensing element TEMP(l) > TEMP SET , the control signal generated by the generator 30 individually reduces the amplitude AMP E(1) of the RF voltage applied to the first electrode region E(l) , while keeping the duty cycle DUTYCYCLE E ⁇ 1) for the first electrode region E(l) the same.
- the control signal of the generator 30 increases the amplitude AMP E(2) of the pulse applied to the second electrode region E(2) , while keeping the duty cycle DUTYCYCLE- ⁇ j for the second electrode region E(2) the same as DUTYCYCLE- :(1) , and so on. If the temperature sensed by a given sensing element is at the set point temperature TEMP SET , no change in RF voltage amplitude is made for the associated electrode region.
- the generator continuously processes voltage difference inputs during successive data acquisition periods to individually adjust AMP E(J) at each electrode region E(J) , while keeping the collective duty cycle the same for all electrode regions E(J) . In this way, the mode maintains a desired uniformity of temperature along the length of the ablating element.
- the generator takes into account not only instantaneous changes that occur in a given sample period, but also changes that have occurred in previous sample periods and the rate at which these changes are varying over time.
- PID proportional integral differential
- the generator will respond differently to a given proportionally large instantaneous difference between TEMP (J) and TEMP SET , depending upon whether the difference is getting larger or smaller, compared to previous instantaneous differences, and whether the rate at which the difference is changing since previous sample periods is increasing or decreasing.
- Further details of individual amplitude/collective duty cycle control for segmented electrode regions based upon temperature sensing are found in copending U.S. Application Serial No. 08/439,824, filed May 12, 1995 and entitled "Systems and Methods for Controlling Tissue Ablation Using Multiple Temperature Sensing Elements," which is incorporated herein by reference.
- the controller 32 selects at the end of each data acquisition phase the sensed temperature that is the greatest for that phase (TEMP J ⁇ JJ ) .
- the controller 32 also selects for that phase the sensed temperature that is the lowest
- the generator compares the selected hottest sensed temperature TEMP SMAX to a selected high set point temperature TEMP H , SET .
- the comparison generates a control signal that collectively adjusts the amplitude of the RF voltage for all electrodes using proportional, PID, or fuzzy logic control techniques.
- TEMP g ⁇ TEMP HISET , no change in the amplitude of the RF voltage delivered to all segments. It should be appreciated that the generator can select for amplitude control purposes any one of the sensed temperatures TEMP g ⁇ ,,, TEMP ⁇ , or temperatures in between, and compare this temperature condition to a preselected temperature condition.
- the generator governs the delivery of power to the segments based upon difference between a given local temperature TEMP (J) and TEMP ⁇ .
- This implementation computes the difference between local sensed temperature TEMP(J) and TEMP SHJN and compares this difference to a selected set point temperature difference ⁇ TEMP SET . The comparison generates a control signal that governs the delivery of power to the electrode regions.
- the generator turns the given segment E(J) off.
- the generator turns the given segment E(J) back on when TEMP(J) - TEMP ⁇ ,,, ⁇ ⁇ TEMP SET .
- the generator can compare g J MP and TEMP g ,,,,,,,.
- the generator turns all segments off, except the segment where TEMP SMIN exists.
- the controller 231 turns these segments back on when the temperature difference between TEMP SHA ⁇ and TEMP SH , N is less than ⁇ TEMP SET .
- the temperature sensing elements 104 may not measure exactly the maximum temperature at the region 122. This is because the region of hottest temperature occurs beneath the surface of the tissue at a depth of about 0.5 to 2.0 mm from where the energy emitting electrode region 122 (and the associated sensing element 104) contacts the tissue. If the power is applied to heat the tissue too quickly, the actual maximum tissue temperature in this subsurface region may exceed 100° C and lead to tissue desiccation and/or micro-explosions.
- the predictor 400 outputs a predicted temperature of the hottest tissue region T MAXPRE0 (t) .
- the generator 30 derives the amplitude and duty cycle control signals based upon T MAXPRED (t) , in the same manners already described using TEMP(J) .
- the predictor 400 uses a two-layer neural network, although more hidden layers could be used. As shown in Fig.
- the predictor 300 includes a first and second hidden layers and four neurons, designated N (L X) , where L identifies the layer 1 or 2 and X identifies a neuron on that layer.
- TSl(n) and TS2(n) are shown for purposes of illustration, are weighed and inputted to each neuron N ( , 1 ⁇ ; N ( , 2) ; and N ( , 3) of the first layer.
- the output neuron N (2 ,. of the second layer receives as inputs the weighted outputs of the neurons N (1 , ⁇ ; N ( , 2) ; and If, 3) .
- the predictor 400 must be trained on a known set of data containing the temperature of the sensing elements TSl and TS2 and the temperature of the hottest region, which have been previously acquired experimentally. For example, using a back- propagation model, the predictor 400 can be trained to predict the known hottest temperature of the data set with the least mean square error.
- the predictor 300 can be used to predict T NAXPRE0 (t) .
- Other types of data processing techniques can be used to derive T ⁇ p ⁇ t) . See, e.g., copending Patent Application Serial No. 08/266,934, filed June 27, 1994, and entitled "Tissue Heating and Ablation Systems and Methods Using Predicted Temperature for Monitoring and Control.”
- the electrode structure 20 transmits ablation energy to tissue by exposing tissue to an electrically conductive surface 24 carried about the exterior of the expandable-collapsible body 22.
- the alternative embodiments shown in Figs. 41A and 42A include an electrode structure 176 comprising an expandable- collapsible body 178 having an exterior free of an electrically conductive surface. In these embodiments, the body 178 is capacitively coupled to tissue for the purpose of transmitting ablation energy.
- the expandable-collapsible body 178 is molded in same fashion as the body 22 previously described.
- the body 178 includes an electrically conductive structure 180 in contact with at least a portion of the interior surface 182 of the body 178.
- the interior conductive structure 180 can be assembled in various ways.
- the structure 180 comprises an interior shell 184 of electrically conductive material deposited on at least a portion of the interior surface 182 of the body 178.
- the interior shell 184 comprises a material having a relatively high electrical conductivity, as well as a relative high thermal conductivity, such as gold, platinum, platinum/iridium, among others.
- the shell 184 is preferably deposited upon the exterior of the body 178 after molding using deposition process like sputtering, vapor deposition, ion beam deposition, electroplating over a deposited seed layer, or a combination of these processes.
- the body 178 is then everted in the manner previously described (as Fig.
- the body 178 can be caused to assume expanded and collapsed geometries by the introduction of an air or liquid inflation medium, as previously described. Alternatively, the body 178 can employ any previously described interior support structure 44 to affect expansion and collapse.
- the support structures 44 could also by electrically conductive to affect capacitive coupling, with or without the presence of the deposited shell 184. For example, an electrically conductive interior resilient mesh structure (like that shown in Fig. 6) , or a skeleton of flexible, electrically conductive spline elements (like that shown in Fig.
- an open cell foam structure coated with an electrically conductive material can be used both to provide interior support and to provide capacitive coupling between signal wires 186 and tissue, with or without the presence of the deposited interior shell 184.
- one or more signal wires 184 are coupled to the electrically conductive support structures.
- Fig. 41B shows the electrical equivalent circuit 188 of the capacitive coupling effect that the structure 176 in Fig. 41A provides.
- the interface 194 formed among the expandable-collapsible body 178, the conductive structure 180 contacting the inside the body 178, and the tissue 196 contacting the outside of the body 178 functions as a capacitor (designated C ) , whose impedance X c is expressed as:
- f is the frequency of the radio frequency ablation energy 192
- ⁇ is the dielectric constant of the material of the expandable-collapsible body 178, which ranges from about 1.2 to about 10.0
- s is the surface area of the electrically conductive structure 184
- t is the thickness of the body 178 located between the electrically conductive structure 180 and the contacted tissue 196.
- the tissue 196 functions as a resistor (designated ⁇ s ⁇ ) series coupled to C.
- R ⁇ , SSUE is about 100 ohms.
- X c of the structure 180 must be less than R T , SSUE . This relationship assures that the desired ohmic heating effect is concentrated in tissue. To maximize the capacitive coupling effect, it is thereby important to use ablation energy at higher frequencies (for example, between 10 and 20 Mhz) . It is also important to aim to maximize C as much as possible, by controlling thickness of the body 178 as well as by maximizing as much as possible the surface area of contact with the electrically conductive structure 180 inside the body 178. For this reason, a continuous electrically conductive shell 182 or equivalent mesh structure are preferred, compared to a more open spline element structure.
- FIG. 42A shows an alternative embodiment of an expandable-collapsible electrode structure 198 that provides capacitive coupling to tissue.
- the structure 198 comprises an interior electrode 200 of electrically conductive material located within interior of the body 178.
- the interior electrode 200 comprises a material having a relatively high electrical conductivity, as well as a relative high thermal conductivity, such as gold, platinum, platinum/iridium, among others.
- a signal wire 202 is coupled to the electrode to conduct ablation energy to it.
- a hypertonic (i.e., 9%) saline solution 204 fills the interior of the body 178.
- the saline solution 204 serves as an electrically conductive path to convey radio frequency energy from the electrode 200 to the body 178.
- the saline solution 204 also serves as the inflation medium, to cause the body 178 to assume the expanded geometry. Removal of the saline solution 204 causes the body 178 to assume the collapsed geometry.
- Fig. 42B shows the electrical equivalent circuit 206 of the capacitive coupling effect that the structure 198 shown in Fig. 42A provides.
- the interface 212 formed among the expandable-collapsible body 178, the hypertonic saline solution 204 contacting the inside the body 178, and the tissue 196 contacting the outside of the body 178 functions as a capacitor (designated C ) , whose impedance X c is expressed as: ⁇ c 2nfC
- f is the frequency of the radio frequency ablation energy 210
- ⁇ is the dielectric constant of the material of the body 178
- S B is the area of the body 178 contacting the hypertonic saline solution 204, and t is the thickness of the body 178 located between the electrically conductive saline solution 204 and the tissue 196.
- the tissue 196 functions as a resistor (designated R TISSUE ) series coupled to C, which value is about 100 ohms.
- the path 216 through the hypertonic saline 204 between the interior electrode 200 and the interior surface 214 of the body 178 also functions as a resistor (designated R pATH ) series coupled to C.
- the value of R pATH is expressed:
- K is a constant that depends upon the geometry of the structure 198
- S E is the surface area of the interior electrode 200, and p is the resistivity of the hypertonic saline 204.
- the following relationship establishes efficient capacitive coupling between the structure 198 and tissue 196 to achieve the desired ohmic tissue heating effect:
- capacitive coupling provides structural benefits. It isolates possible shell adherence problems to inside the body 178 of the structure 176, where flaking and chipping of the shell 184 can be retained out of the blood pool. Capacitive coupling also avoids potential problems that tissue sticking to exterior conductive materials could create.
- the temperature control of the ablation process is improved using capacitive coupling.
- the tissue- electrode interface is convectively cooled by surrounding blood flow. Due to these convective cooling effects, the region of maximum tissue temperature is located deeper in the tissue. As a result, the temperature conditions sensed by sensing elements associated with metal electrode elements do not directly reflect actual maximum tissue temperature. In this situation, maximum tissue temperature conditions must be inferred or predicted from actual sensed temperatures, as set forth above.
- capacitive coupling in structures 176 or 198 convective cooling of the tissue-electrode interface by the surrounding blood flow is minimized.
- the region of maximum temperature is located at the interface between tissue and the porous electrode.
- the temperature conditions sensed by sensing elements associated with the capacitively coupled structures 176 or 198 will more closely reflect actual maximum tissue.
- IX. Conductive Polymer Surfaces As previously mentioned in conjunction with Fig. 19, all or a portion of the body 22 can comprise an electrically conductive polymer.
- the conductivity of the polymer used preferably has a resistivity close to the resistivity of tissue (i.e., about 500 ohm*cm) .
- the electrically conductive body 22 can be used in association with an interior electrode 200, like that shown in Fig. 42A.
- a hypertonic saline solution 204 also fills the interior of the electrically conductive body 22 (as also shown in Fig. 42A) , to serve as an electrically conductive path to convey radio frequency energy from the electrode 200 to the body 22.
- the electrically conductive body 22 functions as a "leaky” capacitor in transmitting radio frequency energy from the interior electrode 200 to tissue.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1035496P | 1996-01-19 | 1996-01-19 | |
US1022396P | 1996-01-19 | 1996-01-19 | |
US1022596P | 1996-01-19 | 1996-01-19 | |
US60/010,225 | 1996-01-19 | ||
US60/010,223 | 1996-01-19 | ||
US60/010,354 | 1996-01-19 | ||
US08/628,928 US5925038A (en) | 1996-01-19 | 1996-04-08 | Expandable-collapsible electrode structures for capacitive coupling to tissue |
US08/628,928 | 1996-04-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997025929A1 true WO1997025929A1 (en) | 1997-07-24 |
Family
ID=27485980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/001174 WO1997025929A1 (en) | 1996-01-19 | 1997-01-17 | Expandable-collapsible electrode structures for capacitive coupling to tissue |
Country Status (2)
Country | Link |
---|---|
US (4) | US5925038A (US06736811-20040518-M00001.png) |
WO (1) | WO1997025929A1 (US06736811-20040518-M00001.png) |
Families Citing this family (446)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8025661B2 (en) * | 1994-09-09 | 2011-09-27 | Cardiofocus, Inc. | Coaxial catheter instruments for ablation with radiant energy |
US6423055B1 (en) * | 1999-07-14 | 2002-07-23 | Cardiofocus, Inc. | Phototherapeutic wave guide apparatus |
US7229436B2 (en) | 1996-01-05 | 2007-06-12 | Thermage, Inc. | Method and kit for treatment of tissue |
US20030212393A1 (en) * | 1996-01-05 | 2003-11-13 | Knowlton Edward W. | Handpiece with RF electrode and non-volatile memory |
US5925038A (en) * | 1996-01-19 | 1999-07-20 | Ep Technologies, Inc. | Expandable-collapsible electrode structures for capacitive coupling to tissue |
US6036687A (en) * | 1996-03-05 | 2000-03-14 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency |
US7220257B1 (en) | 2000-07-25 | 2007-05-22 | Scimed Life Systems, Inc. | Cryotreatment device and method |
US6652515B1 (en) * | 1997-07-08 | 2003-11-25 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
US6547788B1 (en) * | 1997-07-08 | 2003-04-15 | Atrionx, Inc. | Medical device with sensor cooperating with expandable member |
US6997925B2 (en) * | 1997-07-08 | 2006-02-14 | Atrionx, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
US6514249B1 (en) * | 1997-07-08 | 2003-02-04 | Atrionix, Inc. | Positioning system and method for orienting an ablation element within a pulmonary vein ostium |
US6096037A (en) | 1997-07-29 | 2000-08-01 | Medtronic, Inc. | Tissue sealing electrosurgery device and methods of sealing tissue |
US6159207A (en) * | 1997-07-31 | 2000-12-12 | Yoon; Inbae | Protected ablation method and apparatus |
US6200312B1 (en) * | 1997-09-11 | 2001-03-13 | Vnus Medical Technologies, Inc. | Expandable vein ligator catheter having multiple electrode leads |
US6464699B1 (en) | 1997-10-10 | 2002-10-15 | Scimed Life Systems, Inc. | Method and apparatus for positioning a diagnostic or therapeutic element on body tissue and mask element for use with same |
US6837885B2 (en) * | 1998-05-22 | 2005-01-04 | Scimed Life Systems, Inc. | Surgical probe for supporting inflatable therapeutic devices in contact with tissue in or around body orifices and within tumors |
US6036689A (en) * | 1998-09-24 | 2000-03-14 | Tu; Lily Chen | Ablation device for treating atherosclerotic tissues |
US6156036A (en) * | 1999-06-11 | 2000-12-05 | Alcon Laboratories, Inc. | Surgical handpiece tip |
US6559845B1 (en) * | 1999-06-11 | 2003-05-06 | Pulse Entertainment | Three dimensional animation system and method |
US9033961B2 (en) * | 1999-07-14 | 2015-05-19 | Cardiofocus, Inc. | Cardiac ablation catheters for forming overlapping lesions |
US8540704B2 (en) * | 1999-07-14 | 2013-09-24 | Cardiofocus, Inc. | Guided cardiac ablation catheters |
US7935108B2 (en) | 1999-07-14 | 2011-05-03 | Cardiofocus, Inc. | Deflectable sheath catheters |
US8900219B2 (en) * | 1999-07-14 | 2014-12-02 | Cardiofocus, Inc. | System and method for visualizing tissue during ablation procedures |
ES2299447T3 (es) * | 1999-11-10 | 2008-06-01 | Cytyc Surgical Products | Sistema para detectar perforaciones en una cavidad corporal. |
US20040215235A1 (en) | 1999-11-16 | 2004-10-28 | Barrx, Inc. | Methods and systems for determining physiologic characteristics for treatment of the esophagus |
US6551310B1 (en) * | 1999-11-16 | 2003-04-22 | Robert A. Ganz | System and method of treating abnormal tissue in the human esophagus |
US20060095032A1 (en) | 1999-11-16 | 2006-05-04 | Jerome Jackson | Methods and systems for determining physiologic characteristics for treatment of the esophagus |
US6529756B1 (en) * | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
US6645199B1 (en) * | 1999-11-22 | 2003-11-11 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements contact with body tissue and expandable push devices for use with same |
US6602263B1 (en) * | 1999-11-30 | 2003-08-05 | St. Jude Medical Atg, Inc. | Medical grafting methods and apparatus |
US6546935B2 (en) | 2000-04-27 | 2003-04-15 | Atricure, Inc. | Method for transmural ablation |
US6488680B1 (en) * | 2000-04-27 | 2002-12-03 | Medtronic, Inc. | Variable length electrodes for delivery of irrigated ablation |
DE60138880D1 (de) | 2000-05-03 | 2009-07-16 | Bard Inc C R | Vorrichtung zur mehrdimensionalen darstellung und ablation bei elektrophysiologischen prozeduren |
US6454766B1 (en) * | 2000-05-05 | 2002-09-24 | Scimed Life Systems, Inc. | Microporous electrode structure and method of making the same |
US6656174B1 (en) | 2000-07-20 | 2003-12-02 | Scimed Life Systems, Inc. | Devices and methods for creating lesions in blood vessels without obstructing blood flow |
US6640120B1 (en) * | 2000-10-05 | 2003-10-28 | Scimed Life Systems, Inc. | Probe assembly for mapping and ablating pulmonary vein tissue and method of using same |
US7785323B2 (en) * | 2000-12-04 | 2010-08-31 | Boston Scientific Scimed, Inc. | Loop structure including inflatable therapeutic device |
US20040138621A1 (en) | 2003-01-14 | 2004-07-15 | Jahns Scott E. | Devices and methods for interstitial injection of biologic agents into tissue |
US7740623B2 (en) | 2001-01-13 | 2010-06-22 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US6529775B2 (en) | 2001-01-16 | 2003-03-04 | Alsius Corporation | System and method employing indwelling RF catheter for systemic patient warming by application of dielectric heating |
US6666858B2 (en) * | 2001-04-12 | 2003-12-23 | Scimed Life Systems, Inc. | Cryo balloon for atrial ablation |
US6913579B2 (en) * | 2001-05-01 | 2005-07-05 | Surgrx, Inc. | Electrosurgical working end and method for obtaining tissue samples for biopsy |
US6606522B2 (en) | 2001-05-30 | 2003-08-12 | Cardiac Pacemakers, Inc. | Torque mechanism and method for endocardial leads |
US6701191B2 (en) | 2001-05-30 | 2004-03-02 | Cardiac Pacemakers, Inc. | Lead having composite tubing |
US7257449B2 (en) * | 2001-05-30 | 2007-08-14 | Cardiac Pacemakers, Inc. | Extendable/retractable lead having downsized lead body |
US6620159B2 (en) * | 2001-06-06 | 2003-09-16 | Scimed Life Systems, Inc. | Conductive expandable electrode body and method of manufacturing the same |
US6953469B2 (en) * | 2001-08-30 | 2005-10-11 | Ethicon, Inc, | Device and method for treating intraluminal tissue |
US6802843B2 (en) * | 2001-09-13 | 2004-10-12 | Csaba Truckai | Electrosurgical working end with resistive gradient electrodes |
US6773409B2 (en) | 2001-09-19 | 2004-08-10 | Surgrx Llc | Surgical system for applying ultrasonic energy to tissue |
US7182725B2 (en) | 2001-09-24 | 2007-02-27 | Best Vascular, Inc. | Methods and apparatus employing ionizing radiation for treatment of cardiac arrhythmia |
US6814730B2 (en) * | 2001-10-09 | 2004-11-09 | Hong Li | Balloon catheters for non-continuous lesions |
US20050267464A1 (en) * | 2001-10-18 | 2005-12-01 | Surgrx, Inc. | Electrosurgical instrument and method of use |
US6929644B2 (en) | 2001-10-22 | 2005-08-16 | Surgrx Inc. | Electrosurgical jaw structure for controlled energy delivery |
US7070597B2 (en) * | 2001-10-18 | 2006-07-04 | Surgrx, Inc. | Electrosurgical working end for controlled energy delivery |
US7083619B2 (en) | 2001-10-22 | 2006-08-01 | Surgrx, Inc. | Electrosurgical instrument and method of use |
US20030216732A1 (en) * | 2002-05-20 | 2003-11-20 | Csaba Truckai | Medical instrument with thermochromic or piezochromic surface indicators |
US7041102B2 (en) * | 2001-10-22 | 2006-05-09 | Surgrx, Inc. | Electrosurgical working end with replaceable cartridges |
US7011657B2 (en) | 2001-10-22 | 2006-03-14 | Surgrx, Inc. | Jaw structure for electrosurgical instrument and method of use |
US7311709B2 (en) * | 2001-10-22 | 2007-12-25 | Surgrx, Inc. | Electrosurgical instrument and method of use |
US7189233B2 (en) * | 2001-10-22 | 2007-03-13 | Surgrx, Inc. | Electrosurgical instrument |
US7354440B2 (en) * | 2001-10-22 | 2008-04-08 | Surgrx, Inc. | Electrosurgical instrument and method of use |
US6926716B2 (en) * | 2001-11-09 | 2005-08-09 | Surgrx Inc. | Electrosurgical instrument |
US8075558B2 (en) * | 2002-04-30 | 2011-12-13 | Surgrx, Inc. | Electrosurgical instrument and method |
US6905497B2 (en) * | 2001-10-22 | 2005-06-14 | Surgrx, Inc. | Jaw structure for electrosurgical instrument |
US7753908B2 (en) | 2002-02-19 | 2010-07-13 | Endoscopic Technologies, Inc. (Estech) | Apparatus for securing an electrophysiology probe to a clamp |
US7785324B2 (en) | 2005-02-25 | 2010-08-31 | Endoscopic Technologies, Inc. (Estech) | Clamp based lesion formation apparatus and methods configured to protect non-target tissue |
PT1474031E (pt) * | 2002-01-22 | 2012-03-12 | Surgrx Inc | Instrumento electro-cirúrgico e método de utilização |
US6740081B2 (en) * | 2002-01-25 | 2004-05-25 | Applied Medical Resources Corporation | Electrosurgery with improved control apparatus and method |
US6827715B2 (en) * | 2002-01-25 | 2004-12-07 | Medtronic, Inc. | System and method of performing an electrosurgical procedure |
US7967816B2 (en) | 2002-01-25 | 2011-06-28 | Medtronic, Inc. | Fluid-assisted electrosurgical instrument with shapeable electrode |
US6932816B2 (en) * | 2002-02-19 | 2005-08-23 | Boston Scientific Scimed, Inc. | Apparatus for converting a clamp into an electrophysiology device |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US20040254513A1 (en) * | 2002-04-10 | 2004-12-16 | Sherwin Shang | Conductive polymer materials and applications thereof including monitoring and providing effective therapy |
US7022098B2 (en) | 2002-04-10 | 2006-04-04 | Baxter International Inc. | Access disconnection systems and methods |
US10155082B2 (en) | 2002-04-10 | 2018-12-18 | Baxter International Inc. | Enhanced signal detection for access disconnection systems |
US7052480B2 (en) | 2002-04-10 | 2006-05-30 | Baxter International Inc. | Access disconnection systems and methods |
US7211103B2 (en) * | 2002-04-11 | 2007-05-01 | Second Sight Medical Products, Inc. | Biocompatible bonding method and electronics package suitable for implantation |
US6989009B2 (en) * | 2002-04-19 | 2006-01-24 | Scimed Life Systems, Inc. | Cryo balloon |
US20030225432A1 (en) * | 2002-05-31 | 2003-12-04 | Baptiste Reginald C. | Soft tissue retraction device for an endoscopic instrument |
US9439714B2 (en) * | 2003-04-29 | 2016-09-13 | Atricure, Inc. | Vacuum coagulation probes |
US7063698B2 (en) * | 2002-06-14 | 2006-06-20 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US8235990B2 (en) | 2002-06-14 | 2012-08-07 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US6893442B2 (en) | 2002-06-14 | 2005-05-17 | Ablatrics, Inc. | Vacuum coagulation probe for atrial fibrillation treatment |
US7572257B2 (en) * | 2002-06-14 | 2009-08-11 | Ncontact Surgical, Inc. | Vacuum coagulation and dissection probes |
US7901407B2 (en) | 2002-08-02 | 2011-03-08 | Boston Scientific Scimed, Inc. | Media delivery device for bone structures |
US7087054B2 (en) * | 2002-10-01 | 2006-08-08 | Surgrx, Inc. | Electrosurgical instrument and method of use |
US20040082947A1 (en) * | 2002-10-25 | 2004-04-29 | The Regents Of The University Of Michigan | Ablation catheters |
US20050033137A1 (en) * | 2002-10-25 | 2005-02-10 | The Regents Of The University Of Michigan | Ablation catheters and methods for their use |
US20040153025A1 (en) * | 2003-02-03 | 2004-08-05 | Seifert Paul S. | Systems and methods of de-endothelialization |
US7744583B2 (en) | 2003-02-03 | 2010-06-29 | Boston Scientific Scimed | Systems and methods of de-endothelialization |
US7169146B2 (en) * | 2003-02-14 | 2007-01-30 | Surgrx, Inc. | Electrosurgical probe and method of use |
WO2004082773A2 (en) * | 2003-03-17 | 2004-09-30 | Buzz Bee Toys Inc | Lighted balloon entertainment device |
US7497857B2 (en) * | 2003-04-29 | 2009-03-03 | Medtronic, Inc. | Endocardial dispersive electrode for use with a monopolar RF ablation pen |
US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
US20040267338A1 (en) * | 2003-06-25 | 2004-12-30 | Kent Harrison | Targeted tissue cooling within a body |
US20050010202A1 (en) * | 2003-06-30 | 2005-01-13 | Ethicon, Inc. | Applicator for creating linear lesions for the treatment of atrial fibrillation |
US7438714B2 (en) | 2003-09-12 | 2008-10-21 | Boston Scientific Scimed, Inc. | Vacuum-based catheter stabilizer |
US7291146B2 (en) | 2003-09-12 | 2007-11-06 | Minnow Medical, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US7569052B2 (en) * | 2003-09-12 | 2009-08-04 | Boston Scientific Scimed, Inc. | Ablation catheter with tissue protecting assembly |
US20050059963A1 (en) * | 2003-09-12 | 2005-03-17 | Scimed Life Systems, Inc. | Systems and method for creating transmural lesions |
US20050059862A1 (en) * | 2003-09-12 | 2005-03-17 | Scimed Life Systems, Inc. | Cannula with integrated imaging and optical capability |
US7736362B2 (en) * | 2003-09-15 | 2010-06-15 | Boston Scientific Scimed, Inc. | Catheter balloons |
US7309849B2 (en) * | 2003-11-19 | 2007-12-18 | Surgrx, Inc. | Polymer compositions exhibiting a PTC property and methods of fabrication |
US8002770B2 (en) | 2003-12-02 | 2011-08-23 | Endoscopic Technologies, Inc. (Estech) | Clamp based methods and apparatus for forming lesions in tissue and confirming whether a therapeutic lesion has been formed |
US7150745B2 (en) | 2004-01-09 | 2006-12-19 | Barrx Medical, Inc. | Devices and methods for treatment of luminal tissue |
US7632269B2 (en) * | 2004-01-16 | 2009-12-15 | Ethicon Endo-Surgery, Inc. | Electrosurgical instrument with replaceable cartridge |
US7371231B2 (en) * | 2004-02-02 | 2008-05-13 | Boston Scientific Scimed, Inc. | System and method for performing ablation using a balloon |
US20050187545A1 (en) * | 2004-02-20 | 2005-08-25 | Hooven Michael D. | Magnetic catheter ablation device and method |
US7955331B2 (en) * | 2004-03-12 | 2011-06-07 | Ethicon Endo-Surgery, Inc. | Electrosurgical instrument and method of use |
WO2005112813A1 (en) * | 2004-05-17 | 2005-12-01 | C.R. Bard, Inc. | Method and apparatus for mapping and7or ablation of cardiac tissue |
JP2007537832A (ja) * | 2004-05-17 | 2007-12-27 | シー・アール・バード・インコーポレーテッド | 心室頻拍症を治療するためのマッピング及び切除法 |
GB0411348D0 (en) * | 2004-05-21 | 2004-06-23 | Univ Cranfield | Fabrication of polymeric structures using laser initiated polymerisation |
WO2005120376A2 (en) | 2004-06-02 | 2005-12-22 | Medtronic, Inc. | Ablation device with jaws |
US20050273095A1 (en) * | 2004-06-07 | 2005-12-08 | Scimed Life Systems, Inc. | Ablation catheters having anchoring capability and methods of using same |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
US7753907B2 (en) | 2004-10-29 | 2010-07-13 | Boston Scientific Scimed, Inc. | Medical device systems and methods |
US7682378B2 (en) * | 2004-11-10 | 2010-03-23 | Dfine, Inc. | Bone treatment systems and methods for introducing an abrading structure to abrade bone |
US8617152B2 (en) | 2004-11-15 | 2013-12-31 | Medtronic Ablation Frontiers Llc | Ablation system with feedback |
US20060111765A1 (en) * | 2004-11-19 | 2006-05-25 | Seacoast Technologies, Inc. | Medical device for thermally affecting tissue having an inflatable circumferential stiffening member |
US8562607B2 (en) * | 2004-11-19 | 2013-10-22 | Dfine, Inc. | Bone treatment systems and methods |
US7429261B2 (en) * | 2004-11-24 | 2008-09-30 | Ablation Frontiers, Inc. | Atrial ablation catheter and method of use |
US7468062B2 (en) * | 2004-11-24 | 2008-12-23 | Ablation Frontiers, Inc. | Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use |
US7862561B2 (en) * | 2005-01-08 | 2011-01-04 | Boston Scientific Scimed, Inc. | Clamp based lesion formation apparatus with variable spacing structures |
US7776033B2 (en) * | 2005-01-08 | 2010-08-17 | Boston Scientific Scimed, Inc. | Wettable structures including conductive fibers and apparatus including the same |
US7727231B2 (en) * | 2005-01-08 | 2010-06-01 | Boston Scientific Scimed, Inc. | Apparatus and methods for forming lesions in tissue and applying stimulation energy to tissue in which lesions are formed |
US20060155343A1 (en) | 2005-01-11 | 2006-07-13 | Vilims Bradley D | Combination electrical stimulating and infusion medical device and method |
US20080009927A1 (en) * | 2005-01-11 | 2008-01-10 | Vilims Bradley D | Combination Electrical Stimulating and Infusion Medical Device and Method |
US8066702B2 (en) * | 2005-01-11 | 2011-11-29 | Rittman Iii William J | Combination electrical stimulating and infusion medical device and method |
US7945331B2 (en) * | 2005-01-11 | 2011-05-17 | Bradley D. Vilims | Combination electrical stimulating and infusion medical device and method |
US7860556B2 (en) | 2005-02-02 | 2010-12-28 | Voyage Medical, Inc. | Tissue imaging and extraction systems |
US20080015569A1 (en) | 2005-02-02 | 2008-01-17 | Voyage Medical, Inc. | Methods and apparatus for treatment of atrial fibrillation |
US10064540B2 (en) | 2005-02-02 | 2018-09-04 | Intuitive Surgical Operations, Inc. | Visualization apparatus for transseptal access |
US8078266B2 (en) | 2005-10-25 | 2011-12-13 | Voyage Medical, Inc. | Flow reduction hood systems |
US7930016B1 (en) | 2005-02-02 | 2011-04-19 | Voyage Medical, Inc. | Tissue closure system |
US9510732B2 (en) | 2005-10-25 | 2016-12-06 | Intuitive Surgical Operations, Inc. | Methods and apparatus for efficient purging |
US7860555B2 (en) * | 2005-02-02 | 2010-12-28 | Voyage Medical, Inc. | Tissue visualization and manipulation system |
US8050746B2 (en) * | 2005-02-02 | 2011-11-01 | Voyage Medical, Inc. | Tissue visualization device and method variations |
US7918787B2 (en) * | 2005-02-02 | 2011-04-05 | Voyage Medical, Inc. | Tissue visualization and manipulation systems |
US8137333B2 (en) | 2005-10-25 | 2012-03-20 | Voyage Medical, Inc. | Delivery of biological compounds to ischemic and/or infarcted tissue |
US11478152B2 (en) | 2005-02-02 | 2022-10-25 | Intuitive Surgical Operations, Inc. | Electrophysiology mapping and visualization system |
US7862562B2 (en) * | 2005-02-25 | 2011-01-04 | Boston Scientific Scimed, Inc. | Wrap based lesion formation apparatus and methods configured to protect non-target tissue |
EP3045110B1 (en) | 2005-03-28 | 2019-07-31 | Vessix Vascular, Inc. | Intraluminal electrical tissue characterization and tuned rf energy for selective treatment of atheroma and other target tissues |
CN100465827C (zh) * | 2005-03-29 | 2009-03-04 | 华为技术有限公司 | 多媒体终端及其进行状态转换的方法 |
US20060241733A1 (en) * | 2005-04-25 | 2006-10-26 | Cardiac Pacemakers, Inc. | Atrial pacing lead |
US20060271032A1 (en) * | 2005-05-26 | 2006-11-30 | Chin Albert K | Ablation instruments and methods for performing abalation |
US8932208B2 (en) * | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
US20060275933A1 (en) * | 2005-06-02 | 2006-12-07 | Applied Materials, Inc. | Thermally conductive ceramic tipped contact thermocouple |
US20060289795A1 (en) * | 2005-06-02 | 2006-12-28 | Dubois Dale R | Vacuum reaction chamber with x-lamp heater |
US7777197B2 (en) | 2005-06-02 | 2010-08-17 | Applied Materials, Inc. | Vacuum reaction chamber with x-lamp heater |
AU2006262447A1 (en) | 2005-06-20 | 2007-01-04 | Medtronic Ablation Frontiers Llc | Ablation catheter |
EP1909679B1 (en) | 2005-07-11 | 2013-11-20 | Medtronic Ablation Frontiers LLC | Low power tissue ablation system |
US8945151B2 (en) * | 2005-07-13 | 2015-02-03 | Atricure, Inc. | Surgical clip applicator and apparatus including the same |
US20160374747A9 (en) * | 2005-07-15 | 2016-12-29 | Atricure, Inc. | Ablation Device with Sensor |
US8657814B2 (en) | 2005-08-22 | 2014-02-25 | Medtronic Ablation Frontiers Llc | User interface for tissue ablation system |
US7963940B2 (en) * | 2005-08-22 | 2011-06-21 | Boston Scientific Scimed, Inc. | Local perfusion device |
US9084546B2 (en) * | 2005-08-31 | 2015-07-21 | The Regents Of The University Of Michigan | Co-electrodeposited hydrogel-conducting polymer electrodes for biomedical applications |
US8005526B2 (en) * | 2005-08-31 | 2011-08-23 | The Regents Of The University Of Michigan | Biologically integrated electrode devices |
US20070083192A1 (en) * | 2005-10-07 | 2007-04-12 | Eric Welch | Apparatus and method for ablation of targeted tissue |
US8221310B2 (en) | 2005-10-25 | 2012-07-17 | Voyage Medical, Inc. | Tissue visualization device and method variations |
US8702694B2 (en) | 2005-11-23 | 2014-04-22 | Covidien Lp | Auto-aligning ablating device and method of use |
US7959627B2 (en) | 2005-11-23 | 2011-06-14 | Barrx Medical, Inc. | Precision ablating device |
US7997278B2 (en) | 2005-11-23 | 2011-08-16 | Barrx Medical, Inc. | Precision ablating method |
US20090177111A1 (en) * | 2006-12-06 | 2009-07-09 | Miller Stephan P | System and method for displaying contact between a catheter and tissue |
US9492226B2 (en) * | 2005-12-06 | 2016-11-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Graphical user interface for real-time RF lesion depth display |
US8603084B2 (en) | 2005-12-06 | 2013-12-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the formation of a lesion in tissue |
US9254163B2 (en) | 2005-12-06 | 2016-02-09 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Assessment of electrode coupling for tissue ablation |
US10362959B2 (en) * | 2005-12-06 | 2019-07-30 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the proximity of an electrode to tissue in a body |
US8317783B2 (en) * | 2005-12-06 | 2012-11-27 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Assessment of electrode coupling for tissue ablation |
US8449535B2 (en) * | 2005-12-06 | 2013-05-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
CN101534736B (zh) | 2005-12-06 | 2013-05-08 | 圣朱德医疗有限公司房颤分公司 | 用于组织消融的电极耦合评估 |
US8998890B2 (en) * | 2005-12-06 | 2015-04-07 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Assessment of electrode coupling for tissue ablation |
US8403925B2 (en) | 2006-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing lesions in tissue |
US8406866B2 (en) | 2005-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
US7704248B2 (en) | 2005-12-21 | 2010-04-27 | Boston Scientific Scimed, Inc. | Ablation device with compression balloon |
US7867176B2 (en) * | 2005-12-27 | 2011-01-11 | Cordis Corporation | Variable stiffness guidewire |
US20070185479A1 (en) * | 2006-02-06 | 2007-08-09 | Liming Lau | Methods and devices for performing ablation and assessing efficacy thereof |
US20070225697A1 (en) * | 2006-03-23 | 2007-09-27 | Ketan Shroff | Apparatus and methods for cardiac ablation |
US7785317B2 (en) | 2006-03-29 | 2010-08-31 | Codman & Shurtleff, Inc. | Joined metal tubing and method of manufacture |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US8118859B2 (en) * | 2006-05-26 | 2012-02-21 | Codman & Shurtleff, Inc. | Occlusion device combination of stent and mesh having offset parallelogram porosity |
US8690938B2 (en) * | 2006-05-26 | 2014-04-08 | DePuy Synthes Products, LLC | Occlusion device combination of stent and mesh with diamond-shaped porosity |
US9414883B2 (en) * | 2006-06-09 | 2016-08-16 | Boston Scientific Scimed, Inc. | Co-access foam/electrode introducer |
US7670353B2 (en) * | 2006-06-12 | 2010-03-02 | Codman & Shurtleff, Inc. | Modified headpiece for hydraulic coil deployment system |
US7766935B2 (en) | 2006-06-12 | 2010-08-03 | Codman & Shurtleff, Inc. | Modified headpiece for hydraulic coil deployment system |
WO2007146215A2 (en) * | 2006-06-12 | 2007-12-21 | Pankaj Patel | Endoscopically introducible expandable cautery device |
US9055906B2 (en) | 2006-06-14 | 2015-06-16 | Intuitive Surgical Operations, Inc. | In-vivo visualization systems |
US8585732B2 (en) * | 2006-06-14 | 2013-11-19 | DePuy Synthes Products, LLC | Retrieval device with sidewall grippers |
US9814511B2 (en) | 2006-06-28 | 2017-11-14 | Medtronic Cryocath Lp | Variable geometry cooling chamber |
US20080039879A1 (en) * | 2006-08-09 | 2008-02-14 | Chin Albert K | Devices and methods for atrial appendage exclusion |
US8936794B2 (en) * | 2006-08-25 | 2015-01-20 | The Regents Of The University Of Michigan | Conducting polymer nanotube actuators for precisely controlled release of medicine and bioactive molecules |
US10004388B2 (en) | 2006-09-01 | 2018-06-26 | Intuitive Surgical Operations, Inc. | Coronary sinus cannulation |
US20080097476A1 (en) * | 2006-09-01 | 2008-04-24 | Voyage Medical, Inc. | Precision control systems for tissue visualization and manipulation assemblies |
WO2008028149A2 (en) | 2006-09-01 | 2008-03-06 | Voyage Medical, Inc. | Electrophysiology mapping and visualization system |
US10022181B2 (en) * | 2006-09-27 | 2018-07-17 | Medtronic Cryocath Lp | Thermocouple mesh system for a medical device |
AU2007310988B2 (en) | 2006-10-18 | 2013-08-15 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
JP5559539B2 (ja) | 2006-10-18 | 2014-07-23 | べシックス・バスキュラー・インコーポレイテッド | 身体組織に望ましい温度作用を誘発するシステム |
WO2008049082A2 (en) | 2006-10-18 | 2008-04-24 | Minnow Medical, Inc. | Inducing desirable temperature effects on body tissue |
US10335131B2 (en) | 2006-10-23 | 2019-07-02 | Intuitive Surgical Operations, Inc. | Methods for preventing tissue migration |
EP2076186B1 (en) * | 2006-10-25 | 2015-03-04 | Koninklijke Philips N.V. | Instrument with an inflatable balloon |
WO2008057118A1 (en) * | 2006-11-09 | 2008-05-15 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US20080183036A1 (en) | 2006-12-18 | 2008-07-31 | Voyage Medical, Inc. | Systems and methods for unobstructed visualization and ablation |
US9226648B2 (en) | 2006-12-21 | 2016-01-05 | Intuitive Surgical Operations, Inc. | Off-axis visualization systems |
US8131350B2 (en) | 2006-12-21 | 2012-03-06 | Voyage Medical, Inc. | Stabilization of visualization catheters |
JP4974155B2 (ja) * | 2007-04-02 | 2012-07-11 | ヤマハモーターパワープロダクツ株式会社 | 遮音型エンジン発電機 |
US8496653B2 (en) | 2007-04-23 | 2013-07-30 | Boston Scientific Scimed, Inc. | Thrombus removal |
WO2008134457A1 (en) | 2007-04-27 | 2008-11-06 | Voyage Medical, Inc. | Complex shape steerable tissue visualization and manipulation catheter |
US8641711B2 (en) | 2007-05-04 | 2014-02-04 | Covidien Lp | Method and apparatus for gastrointestinal tract ablation for treatment of obesity |
US8657805B2 (en) | 2007-05-08 | 2014-02-25 | Intuitive Surgical Operations, Inc. | Complex shape steerable tissue visualization and manipulation catheter |
US8224416B2 (en) | 2007-05-09 | 2012-07-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Basket catheter having multiple electrodes |
US8588885B2 (en) | 2007-05-09 | 2013-11-19 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Bendable catheter arms having varied flexibility |
WO2008141238A1 (en) | 2007-05-11 | 2008-11-20 | Voyage Medical, Inc. | Visual electrode ablation systems |
US8641704B2 (en) | 2007-05-11 | 2014-02-04 | Medtronic Ablation Frontiers Llc | Ablation therapy system and method for treating continuous atrial fibrillation |
ITBA20070049A1 (it) * | 2007-06-14 | 2008-12-15 | Massimo Grimaldi | Cateteri per ablazione transcatetere per via percutanea di aritmie cardiache mediante radiofrequenza bipolare |
US8784338B2 (en) | 2007-06-22 | 2014-07-22 | Covidien Lp | Electrical means to normalize ablational energy transmission to a luminal tissue surface of varying size |
CA2692669A1 (en) | 2007-07-06 | 2009-01-15 | Barrx Medical, Inc. | Ablation in the gastrointestinal tract to achieve hemostasis and eradicate lesions with a propensity for bleeding |
US8251992B2 (en) | 2007-07-06 | 2012-08-28 | Tyco Healthcare Group Lp | Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight-loss operation |
AU2008279121B2 (en) * | 2007-07-24 | 2013-09-19 | Boston Scientific Scimed, Inc. | System and method for controlling power based on impedance detection, such as controlling power to tissue treatment devices |
US8273012B2 (en) | 2007-07-30 | 2012-09-25 | Tyco Healthcare Group, Lp | Cleaning device and methods |
US8646460B2 (en) | 2007-07-30 | 2014-02-11 | Covidien Lp | Cleaning device and methods |
US8235985B2 (en) | 2007-08-31 | 2012-08-07 | Voyage Medical, Inc. | Visualization and ablation system variations |
WO2009045265A1 (en) * | 2007-10-05 | 2009-04-09 | Maquet Cardiovascular, Llc | Devices and methods for minimally-invasive surgical procedures |
US8500731B2 (en) * | 2007-12-21 | 2013-08-06 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Adjustable length flexible polymer electrode catheter and method for ablation |
US9675410B2 (en) * | 2007-12-28 | 2017-06-13 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Flexible polymer electrode for MRI-guided positioning and radio frequency ablation |
US8290578B2 (en) | 2007-12-28 | 2012-10-16 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and apparatus for complex impedance compensation |
US9204927B2 (en) | 2009-05-13 | 2015-12-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for presenting information representative of lesion formation in tissue during an ablation procedure |
EP2082777A1 (en) * | 2008-01-27 | 2009-07-29 | Oncotherm Kft. | Flexible and porous large-area electrode for heating |
US8858609B2 (en) | 2008-02-07 | 2014-10-14 | Intuitive Surgical Operations, Inc. | Stent delivery under direct visualization |
US20090209986A1 (en) * | 2008-02-15 | 2009-08-20 | Stewart Michael C | Devices, Tools and Methods for Atrial Appendage Exclusion |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
WO2009113064A2 (en) * | 2008-03-11 | 2009-09-17 | Hayim Lindenbaum | A diagnostic medical device for endoscopic use |
US20090292325A1 (en) * | 2008-05-02 | 2009-11-26 | Cederna Paul S | Hybrid bioelectrical interface device |
KR101719824B1 (ko) | 2008-05-09 | 2017-04-04 | 호라이라 인코포레이티드 | 기관지나무 치료용 시스템, 어셈블리 및 방법 |
US8128617B2 (en) | 2008-05-27 | 2012-03-06 | Boston Scientific Scimed, Inc. | Electrical mapping and cryo ablating with a balloon catheter |
US9101735B2 (en) | 2008-07-07 | 2015-08-11 | Intuitive Surgical Operations, Inc. | Catheter control systems |
US8114043B2 (en) | 2008-07-25 | 2012-02-14 | Baxter International Inc. | Electromagnetic induction access disconnect sensor |
US8894643B2 (en) * | 2008-10-10 | 2014-11-25 | Intuitive Surgical Operations, Inc. | Integral electrode placement and connection systems |
US8333012B2 (en) | 2008-10-10 | 2012-12-18 | Voyage Medical, Inc. | Method of forming electrode placement and connection systems |
US8197477B2 (en) | 2008-10-21 | 2012-06-12 | Hermes Innovations Llc | Tissue ablation methods |
US8540708B2 (en) * | 2008-10-21 | 2013-09-24 | Hermes Innovations Llc | Endometrial ablation method |
US8372068B2 (en) * | 2008-10-21 | 2013-02-12 | Hermes Innovations, LLC | Tissue ablation systems |
US8500732B2 (en) * | 2008-10-21 | 2013-08-06 | Hermes Innovations Llc | Endometrial ablation devices and systems |
US8821486B2 (en) | 2009-11-13 | 2014-09-02 | Hermes Innovations, LLC | Tissue ablation systems and methods |
US9662163B2 (en) | 2008-10-21 | 2017-05-30 | Hermes Innovations Llc | Endometrial ablation devices and systems |
US8197476B2 (en) | 2008-10-21 | 2012-06-12 | Hermes Innovations Llc | Tissue ablation systems |
US9795442B2 (en) | 2008-11-11 | 2017-10-24 | Shifamed Holdings, Llc | Ablation catheters |
CA2743140A1 (en) * | 2008-11-11 | 2010-05-20 | Shifamed, Llc | Low profile electrode assembly |
US9468364B2 (en) | 2008-11-14 | 2016-10-18 | Intuitive Surgical Operations, Inc. | Intravascular catheter with hood and image processing systems |
KR20110104504A (ko) | 2008-11-17 | 2011-09-22 | 미노우 메디컬, 인코포레이티드 | 조직 토폴로지의 지식 여하에 따른 에너지의 선택적 축적 |
DE102008062018A1 (de) * | 2008-12-12 | 2010-06-17 | Up Management Gmbh | Vorrichtung und Verfahren zur Erfassung elektrischer Potentiale am menschlichen oder tierischen Körper |
US20100160906A1 (en) * | 2008-12-23 | 2010-06-24 | Asthmatx, Inc. | Expandable energy delivery devices having flexible conductive elements and associated systems and methods |
US7955299B2 (en) | 2008-12-29 | 2011-06-07 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Seal for controlling irrigation in basket catheters |
US9339331B2 (en) | 2008-12-29 | 2016-05-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Non-contact electrode basket catheters with irrigation |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
CN102481433B (zh) * | 2009-06-24 | 2014-12-31 | 施菲姆德控股有限责任公司 | 可转向医疗输送装置 |
WO2011041629A2 (en) * | 2009-10-02 | 2011-04-07 | Cardiofocus, Inc. | Cardiac ablation system with pulsed aiming light |
WO2011041635A2 (en) * | 2009-10-02 | 2011-04-07 | Cardiofocus, Inc. | Cardiac ablation system with inflatable member having multiple inflation settings |
US20110082452A1 (en) * | 2009-10-02 | 2011-04-07 | Cardiofocus, Inc. | Cardiac ablation system with automatic safety shut-off feature |
US8702688B2 (en) * | 2009-10-06 | 2014-04-22 | Cardiofocus, Inc. | Cardiac ablation image analysis system and process |
CA2778274C (en) * | 2009-10-26 | 2017-10-24 | Hermes Innovations Llc | Endometrial ablation devices and system |
CN112089394A (zh) | 2009-10-27 | 2020-12-18 | 努瓦拉公司 | 具有可冷却的能量发射组件的递送装置 |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US8343078B2 (en) | 2009-11-11 | 2013-01-01 | Minerva Surgical, Inc. | Methods for evaluating the integrity of a uterine cavity |
US8715278B2 (en) | 2009-11-11 | 2014-05-06 | Minerva Surgical, Inc. | System for endometrial ablation utilizing radio frequency |
EP2842510B1 (en) | 2009-11-11 | 2022-08-24 | Nuvaira, Inc. | Device for treating tissue and controlling stenosis |
US9289257B2 (en) | 2009-11-13 | 2016-03-22 | Minerva Surgical, Inc. | Methods and systems for endometrial ablation utilizing radio frequency |
US11896282B2 (en) | 2009-11-13 | 2024-02-13 | Hermes Innovations Llc | Tissue ablation systems and method |
US8529562B2 (en) | 2009-11-13 | 2013-09-10 | Minerva Surgical, Inc | Systems and methods for endometrial ablation |
US8694071B2 (en) | 2010-02-12 | 2014-04-08 | Intuitive Surgical Operations, Inc. | Image stabilization techniques and methods |
US8926629B2 (en) | 2010-02-24 | 2015-01-06 | Minerva Surgical, Inc. | Systems and methods for endometrial ablation |
US9421059B2 (en) | 2010-04-27 | 2016-08-23 | Minerva Surgical, Inc. | Device for endometrial ablation having an expandable seal for a cervical canal |
WO2011119857A2 (en) | 2010-03-24 | 2011-09-29 | Shifamed, Llc | Intravascular tissue disruption |
US9814522B2 (en) | 2010-04-06 | 2017-11-14 | Intuitive Surgical Operations, Inc. | Apparatus and methods for ablation efficacy |
EP2555699B1 (en) | 2010-04-09 | 2019-04-03 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US20120116378A1 (en) * | 2010-04-26 | 2012-05-10 | Minerva Surgical, Inc. | Endometrial ablation with a device that conforms to symmetric or asymmetric uterine cavities |
AU2011252976A1 (en) | 2010-05-12 | 2012-11-08 | Shifamed Holdings, Llc | Low profile electrode assembly |
US9655677B2 (en) | 2010-05-12 | 2017-05-23 | Shifamed Holdings, Llc | Ablation catheters including a balloon and electrodes |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US8956348B2 (en) | 2010-07-21 | 2015-02-17 | Minerva Surgical, Inc. | Methods and systems for endometrial ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9186208B2 (en) | 2010-10-19 | 2015-11-17 | Minerva Surgical, Inc. | Systems for endometrial ablation |
TWI556849B (zh) | 2010-10-21 | 2016-11-11 | 美敦力阿福盧森堡公司 | 用於腎臟神經協調的導管裝置 |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9510897B2 (en) | 2010-11-05 | 2016-12-06 | Hermes Innovations Llc | RF-electrode surface and method of fabrication |
US9259262B2 (en) | 2010-11-09 | 2016-02-16 | Minerva Surgical, Inc. | Systems and methods for endometrial ablation |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US11246653B2 (en) * | 2010-12-07 | 2022-02-15 | Boaz Avitall | Catheter systems for cardiac arrhythmia ablation |
US8998893B2 (en) | 2010-12-07 | 2015-04-07 | Boaz Avitall | Catheter systems for cardiac arrhythmia ablation |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
US9808616B2 (en) | 2011-01-14 | 2017-11-07 | The Regents Of The University Of Michigan | Regenerative peripheral nerve interface |
WO2012100095A1 (en) | 2011-01-19 | 2012-07-26 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US9655557B2 (en) | 2011-02-04 | 2017-05-23 | Minerva Surgical, Inc. | Methods and systems for evaluating the integrity of a uterine cavity |
US8939971B2 (en) | 2011-03-11 | 2015-01-27 | Minerva Surgical, Inc. | System and method for endometrial ablation |
US10278774B2 (en) | 2011-03-18 | 2019-05-07 | Covidien Lp | Selectively expandable operative element support structure and methods of use |
US9050102B2 (en) | 2011-03-23 | 2015-06-09 | Minerva Surgical Inc. | System and method for endometrial ablation |
US9050103B2 (en) | 2011-03-25 | 2015-06-09 | Minerva Surgical Inc. | System and method for endometrial ablation |
KR20130131471A (ko) | 2011-04-08 | 2013-12-03 | 코비디엔 엘피 | 신장 교감 신경의 신경차단 및 이온영동 약물 전달을 위한 이온영동 약물 전달 시스템 및 방법 |
JP5697798B2 (ja) | 2011-04-22 | 2015-04-08 | トペラ インコーポレイテッド | 心臓リズム障害を検出するための可撓性電極アセンブリを有するバスケットスタイル心臓マッピングカテーテル |
TW201242570A (en) | 2011-04-25 | 2012-11-01 | Medtronic Ardian Luxembourg | Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
US20120283713A1 (en) * | 2011-05-02 | 2012-11-08 | Teresa Ann Mihalik | Compliant sleeves coupled with wire structures for cryoablation |
EP2704673B1 (en) * | 2011-05-02 | 2015-10-07 | Medtronic Cryocath LP | Compliant sleeves coupled with wire structures for cryoablation |
US20120283714A1 (en) * | 2011-05-02 | 2012-11-08 | Teresa Ann Mihalik | Methods of treatment with compliant elements and wire structures |
US20130116705A1 (en) | 2011-05-03 | 2013-05-09 | Amr Salahieh | Steerable Delivery Sheaths |
US9788890B2 (en) | 2011-05-06 | 2017-10-17 | Minerva Surgical, Inc. | Methods for evaluating the integrity of a uterine cavity |
AU2012283908B2 (en) | 2011-07-20 | 2017-02-16 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
AU2012287189B2 (en) | 2011-07-22 | 2016-10-06 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
US9387031B2 (en) | 2011-07-29 | 2016-07-12 | Medtronic Ablation Frontiers Llc | Mesh-overlayed ablation and mapping device |
EP2792323B1 (en) | 2011-08-25 | 2017-10-04 | Covidien LP | Systems and devices for treatment of luminal tissue |
WO2013055826A1 (en) | 2011-10-10 | 2013-04-18 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
EP2765940B1 (en) | 2011-10-11 | 2015-08-26 | Boston Scientific Scimed, Inc. | Off-wall electrode device for nerve modulation |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
EP2768563B1 (en) | 2011-10-18 | 2016-11-09 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
WO2013059202A1 (en) | 2011-10-18 | 2013-04-25 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
CN108095821B (zh) | 2011-11-08 | 2021-05-25 | 波士顿科学西美德公司 | 孔部肾神经消融 |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9743978B2 (en) | 2011-12-13 | 2017-08-29 | Minerva Surgical, Inc. | Systems and methods for endometrial ablation |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
AU2012358143B2 (en) | 2011-12-23 | 2015-06-11 | Boston Scientific Scimed, Inc. | Expandable balloon or an electrode pad with a heat sensing device |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US8825130B2 (en) | 2011-12-30 | 2014-09-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrode support structure assemblies |
EP2617456A1 (de) * | 2012-01-19 | 2013-07-24 | VascoMed GmbH | Katheter und Katheteranordnung |
US8961550B2 (en) | 2012-04-17 | 2015-02-24 | Indian Wells Medical, Inc. | Steerable endoluminal punch |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US20140018888A1 (en) * | 2012-07-16 | 2014-01-16 | Boston Scientific Scimed, Inc. | Flow controlled radiofrequency medical balloon |
WO2014032016A1 (en) * | 2012-08-24 | 2014-02-27 | Boston Scientific Scimed, Inc. | Intravascular catheter with a balloon comprising separate microporous regions |
US9113911B2 (en) | 2012-09-06 | 2015-08-25 | Medtronic Ablation Frontiers Llc | Ablation device and method for electroporating tissue cells |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
WO2014047454A2 (en) | 2012-09-21 | 2014-03-27 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
EP2906135A2 (en) | 2012-10-10 | 2015-08-19 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US9364277B2 (en) | 2012-12-13 | 2016-06-14 | Cook Medical Technologies Llc | RF energy controller and method for electrosurgical medical devices |
US9204921B2 (en) | 2012-12-13 | 2015-12-08 | Cook Medical Technologies Llc | RF energy controller and method for electrosurgical medical devices |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
WO2014163987A1 (en) | 2013-03-11 | 2014-10-09 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
WO2014143571A1 (en) * | 2013-03-11 | 2014-09-18 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
JP6139772B2 (ja) | 2013-03-15 | 2017-05-31 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 電極パッドと共に使用するための制御ユニットおよび漏電を推定するための方法 |
EP2967734B1 (en) | 2013-03-15 | 2019-05-15 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9901394B2 (en) | 2013-04-04 | 2018-02-27 | Hermes Innovations Llc | Medical ablation system and method of making |
EP2983603B1 (en) | 2013-04-08 | 2020-03-25 | Apama Medical, Inc. | Cardiac ablation catheters |
US10098694B2 (en) | 2013-04-08 | 2018-10-16 | Apama Medical, Inc. | Tissue ablation and monitoring thereof |
US10349824B2 (en) | 2013-04-08 | 2019-07-16 | Apama Medical, Inc. | Tissue mapping and visualization systems |
JP2016523147A (ja) | 2013-06-21 | 2016-08-08 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 同乗型電極支持体を備えた腎除神経バルーンカテーテル |
WO2014205399A1 (en) | 2013-06-21 | 2014-12-24 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
EP3019106A1 (en) | 2013-07-11 | 2016-05-18 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
EP3019105B1 (en) | 2013-07-11 | 2017-09-13 | Boston Scientific Scimed, Inc. | Devices for nerve modulation |
US9615880B2 (en) | 2013-07-17 | 2017-04-11 | Cook Medical Technologies Llc | Ablation mesh |
CN105682594B (zh) | 2013-07-19 | 2018-06-22 | 波士顿科学国际有限公司 | 螺旋双极电极肾脏去神经支配气囊 |
JP2016527959A (ja) | 2013-07-22 | 2016-09-15 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 腎神経アブレーション用医療器具 |
EP3024405A1 (en) | 2013-07-22 | 2016-06-01 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
CN105473093B (zh) | 2013-08-22 | 2019-02-05 | 波士顿科学国际有限公司 | 具有至肾神经调制球囊的改善的粘附力的柔性电路 |
EP3041425B1 (en) | 2013-09-04 | 2022-04-13 | Boston Scientific Scimed, Inc. | Radio frequency (rf) balloon catheter having flushing and cooling capability |
CN105530885B (zh) | 2013-09-13 | 2020-09-22 | 波士顿科学国际有限公司 | 具有气相沉积覆盖层的消融球囊 |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
EP3057488B1 (en) | 2013-10-14 | 2018-05-16 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US9649125B2 (en) | 2013-10-15 | 2017-05-16 | Hermes Innovations Llc | Laparoscopic device |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
JP6259098B2 (ja) | 2013-10-15 | 2018-01-10 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 医療デバイスおよび同医療デバイスを製造する方法 |
CN105636538B (zh) | 2013-10-18 | 2019-01-15 | 波士顿科学国际有限公司 | 具有柔性导线的球囊导管及其使用和制造的相关方法 |
US20150119877A1 (en) * | 2013-10-25 | 2015-04-30 | Covidien Lp | Electrode ablation balloon catheter |
WO2015061457A1 (en) | 2013-10-25 | 2015-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
US9730600B2 (en) | 2013-10-31 | 2017-08-15 | Boston Scientific Scimed, Inc. | Medical device for high resolution mapping using localized matching |
CN105636514B (zh) | 2013-11-01 | 2020-06-05 | 波士顿科学医学有限公司 | 使用延迟内插的心脏标测 |
US9301713B2 (en) | 2013-11-19 | 2016-04-05 | Pacesetter, Inc. | Method and system to assess mechanical dyssynchrony based on motion data collected by a navigation system |
US10278775B2 (en) | 2013-12-31 | 2019-05-07 | Biosense Webster (Israel) Ltd. | Catheter utilizing optical spectroscopy for measuring tissue contact area |
JP6382989B2 (ja) | 2014-01-06 | 2018-08-29 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 耐引き裂き性フレキシブル回路アセンブリを備える医療デバイス |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
EP3102136B1 (en) | 2014-02-04 | 2018-06-27 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US9532725B2 (en) | 2014-03-07 | 2017-01-03 | Boston Scientific Scimed Inc. | Medical devices for mapping cardiac tissue |
US9687167B2 (en) | 2014-03-11 | 2017-06-27 | Boston Scientific Scimed, Inc. | Medical devices for mapping cardiac tissue |
JP2017513645A (ja) | 2014-04-28 | 2017-06-01 | カーディオフォーカス,インコーポレーテッド | アブレーション処置の際にicg色素組成物を用いて組織を視覚化するためのシステムおよび方法 |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
US10314725B2 (en) | 2014-11-13 | 2019-06-11 | The Regents Of The University Of Michigan | Method for amplifying signals from individual nerve fascicles |
EP3808298B1 (en) | 2014-11-19 | 2023-07-05 | EPiX Therapeutics, Inc. | Systems for high-resolution mapping of tissue |
JP6673598B2 (ja) | 2014-11-19 | 2020-03-25 | エピックス セラピューティクス,インコーポレイテッド | ペーシングを伴う組織の高分解能マッピング |
JP6725178B2 (ja) | 2014-11-19 | 2020-07-15 | エピックス セラピューティクス,インコーポレイテッド | 高分解能電極アセンブリを使用するアブレーション装置、システムおよび方法 |
EP3226744A4 (en) | 2014-12-03 | 2018-08-08 | Cardiofocus, Inc. | System and method for visual confirmation of pulmonary vein isolation during ablation procedures |
US10492856B2 (en) | 2015-01-26 | 2019-12-03 | Hermes Innovations Llc | Surgical fluid management system and method of use |
US9433520B2 (en) | 2015-01-29 | 2016-09-06 | Intact Vascular, Inc. | Delivery device and method of delivery |
US10376308B2 (en) | 2015-02-05 | 2019-08-13 | Axon Therapies, Inc. | Devices and methods for treatment of heart failure by splanchnic nerve ablation |
US9636164B2 (en) | 2015-03-25 | 2017-05-02 | Advanced Cardiac Therapeutics, Inc. | Contact sensing systems and methods |
AU2016243568A1 (en) | 2015-03-27 | 2017-10-05 | Shifamed Holdings, Llc | Steerable medical devices, systems, and methods of use |
JP6820864B2 (ja) | 2015-04-24 | 2021-01-27 | カリラ メディカル インコーポレイテッド | 操向可能な医療器具、システムおよび使用方法 |
WO2016175980A1 (en) | 2015-04-29 | 2016-11-03 | Csaba Truckai | Medical ablation device and method of use |
WO2016176567A1 (en) | 2015-04-29 | 2016-11-03 | Innoblative Designs, Inc. | Cavitary tissue ablation |
CN108289709B (zh) * | 2015-10-21 | 2022-03-04 | 圣犹达医疗用品心脏病学部门有限公司 | 高密度电极标测导管 |
CA3000013C (en) | 2015-10-29 | 2024-04-02 | Innoblative Designs, Inc. | Screen sphere tissue ablation devices and methods |
JP6866367B2 (ja) | 2015-11-09 | 2021-04-28 | カリラ メディカル インコーポレイテッド | 医療器具の操向アセンブリおよび使用方法 |
WO2017087549A1 (en) | 2015-11-16 | 2017-05-26 | Apama Medical, Inc. | Energy delivery devices |
US10993824B2 (en) | 2016-01-01 | 2021-05-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
US11344365B2 (en) | 2016-01-05 | 2022-05-31 | Cardiofocus, Inc. | Ablation system with automated sweeping ablation energy element |
US10052149B2 (en) | 2016-01-20 | 2018-08-21 | RELIGN Corporation | Arthroscopic devices and methods |
US10864039B2 (en) | 2016-02-02 | 2020-12-15 | Innoblative Designs, Inc. | Cavitary tissue ablation system |
WO2017151431A1 (en) | 2016-03-01 | 2017-09-08 | Innoblative Designs, Inc. | Resecting and coagulating tissue |
WO2017156039A1 (en) | 2016-03-09 | 2017-09-14 | CARDIONOMIC, Inc. | Cardiac contractility neurostimulation systems and methods |
CN109069006B (zh) | 2016-03-15 | 2022-08-23 | Epix疗法公司 | 用于灌洗消融的改进的装置、系统和方法 |
EP3445258A4 (en) | 2016-04-22 | 2019-12-04 | Relign Corporation | ARTHROSCOPIC DEVICES AND METHOD |
WO2018005382A1 (en) | 2016-07-01 | 2018-01-04 | Aaron Germain | Arthroscopic devices and methods |
AU2017301911B2 (en) | 2016-07-29 | 2022-07-28 | Axon Therapies, Inc. | Devices, systems, and methods for treatment of heart failure by splanchnic nerve ablation |
US10070921B2 (en) | 2016-10-17 | 2018-09-11 | Innoblative Designs, Inc. | Treatment devices and methods |
WO2018144090A2 (en) | 2016-11-08 | 2018-08-09 | Innoblative Designs, Inc. | Electrosurgical tissue and vessel sealing device |
US10213151B2 (en) | 2017-01-27 | 2019-02-26 | Minerva Surgical, Inc. | Systems and methods for evaluating the integrity of a uterine cavity |
US11020045B2 (en) | 2017-03-17 | 2021-06-01 | Minerva Surgical, Inc. | Systems and methods for evaluating the integrity of a uterine cavity |
WO2018140892A1 (en) | 2017-01-27 | 2018-08-02 | Minerva Surgical, Inc. | Systems and methods for evaluating the integrity of a uterine cavity |
JP2020508152A (ja) * | 2017-02-23 | 2020-03-19 | イノブレイティブ デザインズ, インコーポレイテッド | アブレーションステータス監視およびカスタムアブレーション成形のためのシステムおよび方法 |
USD851245S1 (en) | 2017-04-14 | 2019-06-11 | Cardiofocus, Inc. | Compliant balloon |
CN110809448B (zh) | 2017-04-27 | 2022-11-25 | Epix疗法公司 | 确定导管尖端与组织之间接触的性质 |
US11786297B2 (en) | 2017-07-26 | 2023-10-17 | Innoblative Designs, Inc. | Minimally invasive articulating assembly having ablation capabilities |
US11660218B2 (en) | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
DE102017118568B3 (de) * | 2017-08-15 | 2018-10-31 | Cinogy Gmbh | Plasma-Behandlungsgerät |
AU2018333929A1 (en) | 2017-09-13 | 2020-04-09 | CARDIONOMIC, Inc. | Neurostimulation systems and methods for affecting cardiac contractility |
WO2019059914A2 (en) * | 2017-09-21 | 2019-03-28 | Park Sam Boong | METHODS OF MANUFACTURING ELECTROSURGICAL STYLE |
US10561461B2 (en) | 2017-12-17 | 2020-02-18 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
JP7384798B2 (ja) | 2018-01-15 | 2023-11-21 | カーディオフォーカス,インコーポレーテッド | 自動式アブレーションエネルギー要素を用いるアブレーションシステム |
US11478298B2 (en) | 2018-01-24 | 2022-10-25 | Medtronic Ardian Luxembourg S.A.R.L. | Controlled irrigation for neuromodulation systems and associated methods |
JP7334167B2 (ja) | 2018-01-26 | 2023-08-28 | アクソン セラピーズ,インク. | 内臓神経の血管内アブレーションの為の方法及びデバイス |
US11969205B2 (en) | 2018-05-16 | 2024-04-30 | Minerva Surgical, Inc. | Medical systems for endometrial ablation |
CN112839602A (zh) | 2018-08-13 | 2021-05-25 | 卡迪诺米克公司 | 用于影响心脏收缩性和/或松弛性的系统和方法 |
US11642063B2 (en) | 2018-08-23 | 2023-05-09 | St. Jude Medical, Cardiology Division, Inc. | Curved high density electrode mapping catheter |
US20200205887A1 (en) * | 2018-12-27 | 2020-07-02 | Biosense Webster (Israel) Ltd. | Ablation Balloon Catheter Allowing Blood Flow |
JP2022531658A (ja) | 2019-05-06 | 2022-07-08 | カーディオノミック,インク. | 電気神経調節中に生理学的信号をノイズ除去するためのシステムおよび方法 |
US20200398044A1 (en) * | 2019-05-29 | 2020-12-24 | AtaCor Medical, Inc. | Implantable electrical leads and electrodes |
CN110338939A (zh) * | 2019-06-18 | 2019-10-18 | 金华职业技术学院 | 生物碎片捕捉装置中的驱动器和栅网结构的加工装配方法 |
JP2022537018A (ja) | 2019-06-20 | 2022-08-23 | アクソン セラピーズ,インク. | 内臓神経の血管内アブレーションの方法及びデバイス |
US11554214B2 (en) | 2019-06-26 | 2023-01-17 | Meditrina, Inc. | Fluid management system |
US11413090B2 (en) | 2020-01-17 | 2022-08-16 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4979948A (en) * | 1989-04-13 | 1990-12-25 | Purdue Research Foundation | Method and apparatus for thermally destroying a layer of an organ |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0080536A1 (en) * | 1981-12-02 | 1983-06-08 | Walter Spaa | Cardiac stimulator |
SU1220673A1 (ru) * | 1982-01-27 | 1986-03-30 | Научно-Исследовательский Институт Трансплантологии И Искусственных Органов | Устройство дл внутрисердечной дефибрилл ции |
DE3516830A1 (de) * | 1985-05-10 | 1986-11-13 | Max Dr. 8520 Erlangen Hubmann | Katheter |
US5370671A (en) * | 1991-03-26 | 1994-12-06 | Empi, Inc. | Incontinence electrode apparatus |
US5195969A (en) * | 1991-04-26 | 1993-03-23 | Boston Scientific Corporation | Co-extruded medical balloons and catheter using such balloons |
US5255678A (en) * | 1991-06-21 | 1993-10-26 | Ecole Polytechnique | Mapping electrode balloon |
US5562720A (en) * | 1992-05-01 | 1996-10-08 | Vesta Medical, Inc. | Bipolar/monopolar endometrial ablation device and method |
US5277201A (en) * | 1992-05-01 | 1994-01-11 | Vesta Medical, Inc. | Endometrial ablation apparatus and method |
US5311866A (en) * | 1992-09-23 | 1994-05-17 | Endocardial Therapeutics, Inc. | Heart mapping catheter |
US5293869A (en) * | 1992-09-25 | 1994-03-15 | Ep Technologies, Inc. | Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole |
DE69323374T2 (de) * | 1992-09-30 | 1999-06-10 | Cardiac Pacemakers Inc | Klappbare Kissenelektrode zur Herzentflimmerung mit einem Gebiet ohne Leitern, welches als ein Scharnier dient |
US5334193A (en) * | 1992-11-13 | 1994-08-02 | American Cardiac Ablation Co., Inc. | Fluid cooled ablation catheter |
CA2165829A1 (en) * | 1993-07-01 | 1995-01-19 | John E. Abele | Imaging, electrical potential sensing, and ablation catheters |
US5860974A (en) * | 1993-07-01 | 1999-01-19 | Boston Scientific Corporation | Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft |
US5472441A (en) * | 1993-11-08 | 1995-12-05 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
US5462545A (en) * | 1994-01-31 | 1995-10-31 | New England Medical Center Hospitals, Inc. | Catheter electrodes |
US5598848A (en) * | 1994-03-31 | 1997-02-04 | Ep Technologies, Inc. | Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium |
US5505730A (en) * | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
US5681308A (en) * | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
US5925038A (en) * | 1996-01-19 | 1999-07-20 | Ep Technologies, Inc. | Expandable-collapsible electrode structures for capacitive coupling to tissue |
-
1996
- 1996-04-08 US US08/628,928 patent/US5925038A/en not_active Expired - Lifetime
-
1997
- 1997-01-17 WO PCT/US1997/001174 patent/WO1997025929A1/en active Application Filing
-
1999
- 1999-04-27 US US09/300,936 patent/US6179835B1/en not_active Expired - Fee Related
-
2000
- 2000-12-21 US US09/747,276 patent/US6428536B2/en not_active Expired - Lifetime
-
2002
- 2002-06-11 US US10/170,988 patent/US6736811B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4979948A (en) * | 1989-04-13 | 1990-12-25 | Purdue Research Foundation | Method and apparatus for thermally destroying a layer of an organ |
Also Published As
Publication number | Publication date |
---|---|
US5925038A (en) | 1999-07-20 |
US20010025175A1 (en) | 2001-09-27 |
US6736811B2 (en) | 2004-05-18 |
US20030093069A1 (en) | 2003-05-15 |
US6179835B1 (en) | 2001-01-30 |
US6428536B2 (en) | 2002-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5853411A (en) | Enhanced electrical connections for electrode structures | |
US5846238A (en) | Expandable-collapsible electrode structures with distal end steering or manipulation | |
US5891135A (en) | Stem elements for securing tubing and electrical wires to expandable-collapsible electrode structures | |
US5871483A (en) | Folding electrode structures | |
US5925038A (en) | Expandable-collapsible electrode structures for capacitive coupling to tissue | |
US5891136A (en) | Expandable-collapsible mesh electrode structures | |
WO1997025916A9 (en) | Expandable-collapsible electrode structures with electrically conductive walls | |
WO1997025916A1 (en) | Expandable-collapsible electrode structures with electrically conductive walls | |
US5830213A (en) | Systems for heating and ablating tissue using multifunctional electrode structures | |
US5961513A (en) | Tissue heating and ablation systems and methods using porous electrode structures | |
US5868736A (en) | Systems and methods to control tissue heating or ablation with porous electrode structures | |
US5797903A (en) | Tissue heating and ablation systems and methods using porous electrode structures with electrically conductive surfaces | |
US6475213B1 (en) | Method of ablating body tissue | |
US5846239A (en) | Tissue heating and ablation systems and methods using segmented porous electrode structures | |
US5879348A (en) | Electrode structures formed from flexible, porous, or woven materials | |
US6099526A (en) | Electrode structure including hydrophilic material | |
US6071278A (en) | Tissue heating and ablation systems and methods using porous electrode structures with specified electrical resistivities | |
US5840076A (en) | Tissue heating and ablation systems and methods using electrode structures with distally oriented porous regions | |
US5800432A (en) | Systems and methods for actively cooling ablation electrodes using diodes | |
US6053912A (en) | Systems and methods for sensing sub-surface temperatures in body tissue during ablation with actively cooled electrodes | |
US6030379A (en) | Systems and methods for seeking sub-surface temperature conditions during tissue ablation | |
WO1997025918A9 (en) | Electrode structures formed from flexible, porous, or woven materials | |
US6917834B2 (en) | Devices and methods for creating lesions in endocardial and surrounding tissue to isolate focal arrhythmia substrates | |
US5836874A (en) | Multi-function electrode structures for electrically analyzing and heating body tissue | |
JP2000504242A (ja) | 体の組織を電気的に分析し加熱するための多機能電極構造体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97526306 Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |